US20080194939A1 - Minimally Invasive Surgical Appartus and Methods - Google Patents

Minimally Invasive Surgical Appartus and Methods Download PDF

Info

Publication number
US20080194939A1
US20080194939A1 US11/662,128 US66212805A US2008194939A1 US 20080194939 A1 US20080194939 A1 US 20080194939A1 US 66212805 A US66212805 A US 66212805A US 2008194939 A1 US2008194939 A1 US 2008194939A1
Authority
US
United States
Prior art keywords
signal
therapeutic device
therapeutic
elongate body
transducer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/662,128
Inventor
Robert Julian Dickinson
Andrew Robert Pacey
Martin Terry Rothman
Ajay Kumar Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inari Medical Inc
Original Assignee
ADVOTEK MEDICAL DEVICES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADVOTEK MEDICAL DEVICES Ltd filed Critical ADVOTEK MEDICAL DEVICES Ltd
Assigned to ADVOTEK MEDICAL DEVICES LTD reassignment ADVOTEK MEDICAL DEVICES LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DICKINSON, ROBERT JULIAN, JAIN, AJAY KUMAR, PACEY, ANDREW ROBERT, ROTHMAN, MARTIN TERRY
Assigned to SITE SPECIFIC THERAPIES LTD reassignment SITE SPECIFIC THERAPIES LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ADVOTEK MEDICAL DEVICES LTD
Publication of US20080194939A1 publication Critical patent/US20080194939A1/en
Assigned to LIMFLOW GMBH reassignment LIMFLOW GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SITE SPECIFIC THERAPIES LTD.
Assigned to Inari Medical, Inc. reassignment Inari Medical, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIMFLOW S.A.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/2202Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3478Endoscopic needles, e.g. for infusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1139Side-to-side connections, e.g. shunt or X-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2063Acoustic tracking systems, e.g. using ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • A61B2090/3786Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument receiver only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/378Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
    • A61B2090/3788Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument transmitter only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • A61B2090/3929Active markers

Definitions

  • the invention relates to apparatus and methods for performing percutaneous catheter-based interventional surgery.
  • the invention relates to apparatus and techniques for transvascular interstitial surgery.
  • Minimally invasive surgery allows for surgical devices to be inserted into a patient's body cavity through a small aperture cut.
  • This form of surgery has become increasingly popular as it allows patients treated successfully to suffer less surgical discomfort while retaining the benefits of conventional surgery. Patients treated by such techniques are exposed to lower levels of trauma and their recovery times can be significantly reduced compared to conventional surgical procedures.
  • a balloon catheter may be used to open a partially occluded coronary artery as an alternative to open heart surgery.
  • This technique is known as balloon angioplasty.
  • the balloon catheter is typically a small, hollow, flexible tube that has a balloon near to its distal tip.
  • the catheter is inserted into an artery (usually near the patient's groin) and then guided through the body to the patient's heart.
  • the heart and cardiac arteries are visualized by using X-ray fluoroscopy, and blockages in the heart vessels are identified.
  • a balloon catheter is then inserted in or near the blockage and inflated, thus widening the occluded blood vessel and helping to restore blood flow to the cardiac tissue.
  • balloon angioplasty is not always a suitable measure, especially in acute cases and in cases where a coronary artery is completely occluded.
  • the typical treatment is to employ coronary bypass which involves open-heart surgery.
  • PICVA percutaneous in situ coronary venous arterialization
  • the means for targeting the catheter consist of a combination of X-ray fluoroscopy and an imaging ultrasound probe located on the distal tip of the catheter (e.g. see US-A-2004/0133225). Indeed, such an arrangement is difficult to navigate and localisation of the adjacent vein requires considerable skill on the part of the clinician.
  • the present invention provides means, methods and apparatus for overcoming the problems identified in the prior art. Most notably, the means, methods and apparatus of the invention allow for greatly improved targeting and localisation of the therapy to be administered. Hence, the invention shows particular advantage in treating patients requiring coronary bypass by enabling minimally invasive surgical techniques to be used more successfully than previously known.
  • the invention provides a means for directing therapy within the body of a patient, the means comprising:
  • the therapeutic means is comprised within either the first or the second therapeutic devices.
  • the first and second medical devices are catheters.
  • the first therapeutic device comprises the therapeutic means
  • the first device is also referred to herein as the ‘launching device’.
  • the second therapeutic device does not comprise the therapeutic means it is, thus, also referred to herein as the ‘target device’.
  • a second aspect of the invention provides means for aligning a first therapeutic device located in a first body cavity with a second therapeutic device located in a second body cavity adjacent to the first body cavity, the means comprising:
  • alignment of the first therapeutic device and the second therapeutic device is achieved when the directional signal transmitted by the first therapeutic device is received by the second therapeutic device.
  • a third aspect of the invention provides apparatus for traversing tissue intervening first and second body cavities comprising:
  • the signal transducer on the launching device transmits the directional signal that is capable of being received by the signal receiving transducer on the target device
  • the devices when the signal is received by the signal receiving transducer on target device it is determined that the devices are located in the correct juxtaposition within their respective body cavities such that the traversing means can be extended out of the launching device and traverses the tissue intervening the first and second body cavities.
  • a fourth aspect of the invention provides a method for directing therapy in the body of a patient, comprising:
  • therapy is directed by aligning the first therapeutic device with the second therapeutic device via the directional signal transmitted by the first therapeutic device being received by the second therapeutic device, and administering therapy at a location that is aligned to the path taken by the directional signal.
  • the step of administering therapy comprises creation of an aperture in tissue between the first and second body cavities, thereby allowing fluid communication between the first and second body cavities.
  • the aperture is created at a position that lies along the path taken by the directional signal.
  • FIG. 1 is a representation of an embodiment of the invention in which the launching device directs a signal from a first body cavity to the target device located in an adjacent second body cavity;
  • FIG. 2 is a cross sectional representation along the line of BB in FIG. 1 ;
  • FIG. 3 is a representation of a specific embodiment of the launching device of the invention.
  • FIG. 4 is a representation of a specific embodiment of the target device of the invention.
  • Arrow A shows the reversed direction of blood flow after an arterial-venous stenosis (also called PICVA) has been effected;
  • PICVA arterial-venous stenosis
  • FIG. 5 is a representation of a specific embodiment of the launching device of the invention in which the signal transducer is comprised of an array of signal transducer elements;
  • FIG. 6 is a representation of an embodiment of the invention wherein the launching and target devices comprise centring means
  • FIG. 7 is a representation of a stent in place following a procedure such as arterial-venous stenosis.
  • Interrupted arrow A shows the direction of blood flow through the stent between the first and second body cavities.
  • the launching device ( 10 ) is typically a catheter that consists of an elongate flexible rod-like portion and a tip portion, and which provides a conduit for administering therapy within the body of a patient.
  • the launching device ( 10 ) is suitable for location and movement through a first cavity or vessel ( 30 ) within a patient's body.
  • the elongate portion of the launching device ( 10 ) comprises an outer sheath ( 11 ) that encloses a space, defining a lumen ( 13 ).
  • the space within the lumen ( 13 ) may be suitably partitioned or subdivided as necessary so as to define channels for administering therapy or controlling the positioning of the launching device ( 10 ). Such subdivision may, for instance, be achieved either longitudinally or concentrically in an axial fashion.
  • a signal transducer ( 12 ) is located on the launching device ( 10 ).
  • the signal transducer ( 12 ) provides a signal ( 40 ) that is directed outwards from the first launching device ( 10 ).
  • the signal ( 40 ) is directed radially outward from the launching device ( 10 ) in a direction that is perpendicular to the longitudinal axis of the launching device ( 10 ).
  • the direction of the signal ( 40 ) need not be perpendicular and can be directed at an angle to that of the axis of the launching device ( 10 ).
  • the signal transducer ( 12 ) is, thus, comprised within the signal generating means of the apparatus of the invention.
  • the signal transducer ( 12 ) is connected to signal transmitter ( 50 ).
  • the signal transmitted can be suitably selected from ultrasound or appropriate electromagnetic sources such as a laser, microwave radiation or via radio waves.
  • the signal transmitter ( 50 ) generates an ultrasound signal, which is relayed to the signal transducer ( 12 ), which in turn directs the signal ( 40 ) out of the body cavity ( 30 ) into the surrounding tissue.
  • a second device is located within an adjacent second body cavity or vessel ( 32 ).
  • the first and second body cavities ( 30 and 32 respectively) are separated by intervening tissue ( 34 ), sometimes referred to as interstitial tissue or a septum.
  • the first and second body cavities ( 30 , 32 ) are located next to each other in a parallel fashion for at least a portion of their respective lengths. For example, many of the veins and arteries of the body are known to run in parallel with each other for at least a portion of their overall length.
  • the second device is the target device ( 20 ), which assumes a similar arrangement to that of the first device ( 10 ).
  • the target device ( 20 ) can also be a catheter that consists of an elongate flexible rod-like portion and a tip portion, such that fine movement and positioning of the target device ( 20 ) within the body cavity ( 32 ) can be achieved.
  • the target device ( 20 ) comprises an outer sheath ( 21 ) that encloses a space, defining a lumen ( 23 ).
  • the lumen ( 23 ) can be suitably partitioned as with the launching device ( 10 ).
  • the target device ( 20 ) comprises a receiving transducer ( 22 ) for receiving the signal ( 40 ).
  • the receiving transducer ( 22 ) is comprised within the signal detection means of the apparatus of the invention. In use, when the receiving transducer ( 22 ) receives the signal ( 40 ) transmitted from signal transducer ( 12 ), it transmits the received signal to signal detector ( 60 ). The signal detector ( 60 ) provides an output reading to the user of the apparatus via output display ( 61 ).
  • the transmission and detection of the directed signal ( 40 ) allows for the navigation and positioning of the launching device ( 10 ) relative to the target device ( 20 ).
  • the launching device ( 10 ) and target device ( 20 ) can be maneuvered by the user of the apparatus until the output display ( 61 ) indicates that signal ( 40 ) is being received by the target device ( 40 ).
  • the signal ( 40 ) is an ultrasound signal.
  • the signal ( 40 ) is directional and is emitted by the signal transducer ( 12 ) in shape of a narrow cone or arc—i.e. with the width of the signal band increasing as the distance from the signal transducer ( 12 ) increases.
  • the precision of alignment between the launching device ( 10 ) and the target device ( 20 ) depends not only upon signal detection but also upon the distance between the two devices, as at greater distances the signal bandwidth is also greater. This level of error is referred to as ‘positional uncertainty’. It will be appreciated that a certain level of tolerance exists for positional uncertainty, however, if therapy is to be directed with precision the amount of uncertainty should be minimised.
  • the positional uncertainty (x) i.e. the margin of error on either side of a centre line—will be 1 mm at a perpendicular separation of 5 mm between the launching and target devices ( 10 , 20 ).
  • the positional uncertainty does not exceed around +/ ⁇ 5 mm (that is a total signal bandwidth of 10 mm at the point reception). More preferably, the positional uncertainty should be between around +/ ⁇ 0.01 mm and around +/ ⁇ 4.50 mm. Even more preferably, the positional uncertainty should be between around +/ ⁇ 0.1 mm and around ⁇ 2 mm. Ideally, the positional uncertainty does not exceed around +/ ⁇ 1 mm.
  • the strength of the signal ( 40 ) will also be a determining factor and it will be appreciated that signal strength will diminish significantly as the distance between the launching device ( 10 ) and the target device ( 20 ) increases. This distance is in part determined by the amount of intervening tissue ( 34 ) between the two devices.
  • the signal ( 40 ) is an ultrasound signal, it can be expected that significant deterioration of signal will occur where the launching device ( 10 ) and the target device ( 20 ) a separated by more than around 20 mm of solid tissue. Obviously, the density of the intervening tissue ( 34 ) will also have an effect upon the deterioration of signal ( 40 ) over distance.
  • the frequency of the desired ultrasound signal also determines the thickness of the signal transducer, which for a standard ultrasound ceramic transducer—such as a PZT—will be 0.075 mm at 30 MHz.
  • FIG. 2 shows a cross sectional view of the arrangement in FIG. 1 , along the line BB.
  • the correct orientation of the launching device relative to the target device is an important factor as it is this line of orientation ( 41 ) that determines where the therapy is to be applied.
  • this line of orientation ( 41 ) that determines where the therapy is to be applied.
  • the clinical need for precisional placing of therapy in a patient necessitates a requirement for a directional signal ( 40 ) that is linked to the means for delivering therapy.
  • the user of the apparatus of the invention can administer therapy to the correct location by ensuring that the launching device ( 10 ) and the target device ( 20 ) are correctly positioned via transmission and reception of the signal ( 40 ).
  • the orientation line ( 41 ) denotes not only the direction of signal travel but also the path along which therapy can be administered to the patient.
  • FIG. 3 An embodiment of the invention is shown in FIG. 3 in which the signal transducer ( 120 ) is oriented at an oblique angle relative to the longitudinal axis of the launching device ( 10 ).
  • the signal ( 40 ) is transmitted at an angle that is in the direction of forward travel of the launching device ( 10 ) as it enters a body cavity ( 30 ).
  • the preferred signal beam angle is between around 20° and around 60° to the perpendicular, more preferably between around 30° and around 50° to the perpendicular, and most preferably around 45° to the perpendicular, when 0° corresponds to the longitudinal axis of the launching device in the direction of travel.
  • the launching device ( 10 ) in FIG. 2 also shows an embodiment of the invention in which one means for administering therapy is provided.
  • Launching device ( 10 ) comprises a hollow needle or cannula ( 17 ).
  • the hollow needle ( 17 ) is located in an undeployed or retracted state within the lumen ( 13 ) of launching device ( 10 ).
  • the hollow needle ( 17 ) may be deployed/extended from the launching device ( 10 ) at a time deemed appropriate by the user of the apparatus, via an aperture ( 16 ) in the outer sheath ( 11 ),
  • the aperture ( 16 ) thus, can allow communication between the lumen ( 13 ) and the body cavity ( 30 ).
  • the hollow needle ( 17 ) preferably travels along a path that is parallel to the direction of the signal ( 40 ) and is used to pierce the intervening tissue ( 34 ).
  • the hollow needle makes a transit across the entirety of the intervening tissue ( 34 ) and in doing so allows the launching device ( 10 ) to access the second body cavity ( 32 ).
  • the pathway made by the hollow needle ( 17 ) through the intervening tissue ( 34 ) can be subsequently widened to allow fluid communication between the first body cavity ( 30 ) and the second body cavity ( 32 ).
  • Therapeutic means suitable for use in the invention can comprise devices or instruments selected from the group consisting of a cannula; a laser; a radiation-emitting device; a probe; a drill; a blade; a wire; a needle and appropriate combinations thereof.
  • the hollow needle ( 17 ) comprises a sensor ( 19 ) so as to assist further in determining positional information of the tip of the hollow needle relative to the launching device.
  • the sensor ( 19 ) is capable of detecting changes in hydrostatic pressure.
  • Other sensors that are suitable for use in the apparatus and methods of the invention can include temperature sensors, oxygenation sensors and/or colour sensors
  • the hollow needle can further comprise an additional signal transducer ( 122 ).
  • the signal transducer ( 122 ) is located near the tip of the hollow needle on the end of a guide wire ( 14 ).
  • the signal transducer ( 122 ) can easily be located on the hollow needle if this is preferred.
  • the signal transducer ( 122 ) is driven with a short transmit pulse which produces a non-directional signal pulse. The signal pulse can be detected by the receiving transducer ( 23 ) mounted on the target device ( 20 ).
  • the distance from the incoming guide wire ( 14 ) or hollow needle ( 17 ) to the receiving transducer ( 23 ) and hence the target device ( 20 ), can be determined.
  • the target device ( 20 ) comprises a receiving transducer ( 22 ) for receiving the signal ( 40 ).
  • the receiving transducer ( 22 ) can be unidirectional—i.e. capable of receiving a signal from one direction only—or omnidirectional—i.e. capable of receiving a signal from any direction.
  • a target device ( 20 ) is located within a body cavity ( 32 ).
  • the target device ( 20 ) comprises an omnidirectional ultrasound signal receiving transducer.
  • a reflecting cone ( 601 ) directs the signal ( 40 ) onto a disc-shaped receiving transducer ( 60 ).
  • An acoustically transparent window ( 602 ) separates the reflecting cone ( 601 ) from the receiving transducer ( 60 ).
  • an omnidirectional ultrasound signal receiving transducer can be obtained by locating cylinder of a flexible piezoelectric material such as PVDF (polyvinyldifluoride) around the outer sheath of the target device ( 20 ). In such a way the cylinder acts in an equivalent manner to the receiving transducer ( 60 ).
  • PVDF polyvinyldifluoride
  • FIG. 4 also shows an embodiment of the invention in which the target device ( 20 ) comprises a channel ( 25 ) for administering an agent, such as a therapeutic agent, to a patient.
  • the channel ( 25 ) functions as a conduit to allow application of a blocking material ( 251 ) that serves to obstruct or occlude the body cavity ( 32 ).
  • the blocking material ( 251 ) can be suitably selected from a gel based substance.
  • the placement of the blocking material ( 251 ) can be directed by movement of the target device ( 20 ).
  • the presence of a guide member ( 24 ) within the lumen ( 23 ) of the target device ( 20 ) allows the user of the apparatus to precisely manipulate the position of the target device ( 20 ) as required.
  • Alternative blocking materials ( 251 ) can include embolisation members (such as balloons) and self-expanding stents, for example.
  • the launching device ( 10 ) comprises a signal transducer ( 12 ) that is optionally oriented so that the signal ( 40 ) is transmitted at an angle as shown in FIG. 2 .
  • the signal transducer is in the form of a signal transducer array ( 123 ).
  • the signal transducer array ( 123 ) comprises a plurality of signal transducer elements ( 124 ) which can be oriented collectively and thereby define the signal beam width and angle relative to the launching device ( 10 ).
  • a further advantage of the embodiment shown in FIG. 5 is that the smaller size of the elements ( 124 ) means that the signal transducer does not occupy a significant proportion the lumen ( 13 ) of the launching device ( 10 ).
  • FIG. 5 shows an array of signal transducer elements ( 124 ) that are separately connected to the transmitter ( 50 ) via delays ( 51 ) so that the signals to each element are delayed relative to each other. The delays ensure that the ultrasound wavefronts from each element are aligned to produce a beam of ultrasound ( 40 ) at the requisite angle.
  • the signal ( 40 ) is in the form of visible light
  • an array of LEDs can be used.
  • a further embodiment of the invention provides for the devices to comprise means for centring the respective devices within the body cavities.
  • the centring means comprises an inflatable bladder or balloon ( 111 ) which is located in the lumen ( 13 , 23 ) when in an undeployed state and, when the device ( 10 , 20 ) reaches the desired location within the patient, can be inflated.
  • the balloon ( 111 ) can be annular in shape such that is surrounds the device ( 10 , 20 ) in a doughnut-like fashion.
  • the balloon ( 111 ) can also be arranged such that it inflates on only one or on two opposite sides of the device.
  • FIG. 6 an embodiment of the invention is shown where the balloon ( 111 ) is shown deploying on one side of the launching device ( 10 ).
  • the centring means is comprised of one or more loop structures ( 211 ).
  • the one or more loop structures ( 211 ) are located either in the lumen ( 13 , 23 ) or within recesses made in the outer sheath ( 11 , 21 ) when in an undeployed or retracted state.
  • the one or more loop structures ( 211 ) can be expanded outwardly from the device ( 10 , 20 ), thereby, centring the device ( 10 , 20 ) within the body cavity ( 30 , 32 ).
  • Outward expansion of the loop structures ( 211 ) can be suitably effected by compression of a length of wire, for example, such that it bows outwardly from the outer sheath ( 11 , 21 ).
  • a centring device that adopts this conformation typically comprises a plurality of compressible lengths of wire, or other suitable flexible material, arranged in parallel at radially spaced intervals around the periphery of the outer sheath ( 11 , 21 ). Compression of the plurality of wires can be induced by way of a sliding member (not shown) located proximally and/or distally near to the ends of the plurality of wires.
  • the sliding member is capable of translational movement along the longitudinal axis of the device ( 10 , 20 ).
  • the target device ( 20 ) comprises fully deployed centring means ( 211 ) that has allowed the target device ( 20 ) to be centred within the body cavity ( 32 ).
  • Arrangements for centring the devices within the body cavities include, but are not limited to, expandable Chinese-lantern type devices, reversibly expandable stents, coils, helices and retractable probes or legs.
  • the methods and apparatus of the present invention demonstrate particular utility in cardio-vascular surgery.
  • the apparatus of the invention is used by a clinician to perform the procedure of arterial-venous stenosis (PICVA) so as to enable retroperfusion of cardiac tissue following occlusion of a coronary artery.
  • PICVA arterial-venous stenosis
  • the launching catheter ( 10 ) is inserted into the occluded coronary artery by standard keyhole surgical techniques.
  • the target catheter ( 20 ) is inserted into the coronary vein that runs parallel to the coronary artery.
  • the coronary vein is not occluded and, therefore, provides an alternative channel for blood flow to the cardiac muscle effectively allowing the occlusion in the coronary artery to be bypassed.
  • the launching catheter ( 10 ) comprises a PZT ultrasound transducer ( 12 ) (CTS Piezoelectric Products, Albuquerque, N. Mex.) that is oriented such that a directional ultrasound beam is transmitted at a 45° angle (relative to the longitudinal axis of the launching device) in the direction of blood flow in the artery.
  • the ultrasound transducer ( 12 ) is activated and a 30 MHz directional ultrasound signal ( 40 ) is transmitted from the launching catheter ( 10 ).
  • the target catheter ( 20 ) comprises an omnidirectional ultrasound receiving transducer ( 60 ).
  • both catheters comprise centring means in the form of an annular inflatable balloon ( 111 ).
  • the centring means on the launching catheter ( 10 ) is deployed by the clinician when the launching catheter ( 10 ) is deemed to be in an appropriate location close to the site of the occlusion within the coronary artery. This is typically determined via standard fluoroscopic imaging techniques.
  • the target catheter ( 20 ) is then moved within the adjacent coronary vein until the directed ultrasound signal ( 40 ) is detected by the signal receiving transducer ( 60 ).
  • the centring means ( 111 ) on the target catheter ( 20 ) can be deployed either before or after the signal ( 40 ) is detected.
  • the clinician can be certain that the launching and target catheters ( 10 , 20 ) are correctly located within their respective blood vessels to allow for the arterial-venous stenosis procedure to commence.
  • the target catheter ( 20 ) is used to block blood flow within the coronary vein via administration of a gel blocking material ( 251 ) though a channel ( 25 ) in the target catheter ( 10 ).
  • the blocking material ( 251 ) is administered at a position downstream in terms of the venous blood flow relative to the location of the receiving signal transducer ( 60 ).
  • the clinician is then able to initiate arterial-venous stenosis by deploying a hollow needle ( 17 ) from the launching catheter ( 10 ) substantially along a path that is parallel and close to that taken by the ultrasound signal ( 40 ) though the intervening tissue ( 34 ) between the coronary artery and the coronary vein.
  • the hollow needle ( 17 ) comprises a sensor means ( 19 ) near its tip that detects changes in hydrostatic pressure. Hence, the clinician is able to monitor the transition from arterial pressure to venous pressure as the hollow needle passes between the two vessels.
  • the hollow needle ( 17 ) further comprises a guide member ( 14 ) in the form of a wire located in the bore of the needle.
  • the hollow needle Once the hollow needle has been passed across the intervening tissue ( 34 ) it is retracted leaving the guide wire ( 14 ) in place. Alternatively, once the hollow needle ( 17 ) has made the transition across the intervening tissue ( 34 ) the clinician is able to pass the guide wire ( 14 ) through the bore of the needle and then retract the needle ( 17 ) into the launching catheter ( 10 ).
  • the clinician withdraws the launching catheter ( 10 ) from the patient leaving the guide wire ( 14 ) in place.
  • a further catheter device is then slid along the guide wire ( 14 ) and an expandable stent ( 26 ) is deployed in order to widen the perforation in the intervening tissue ( 34 ) between the coronary artery and vein (see FIG. 7 ).
  • the target catheter ( 20 ) is withdrawn from the patient leaving the blocking material ( 251 ) in position.
  • a further block or suture may be inserted into the coronary vein prevent reversal of arterial blood flow.
  • arterial blood is thereby diverted into the venous system and is enabled to retroperfuse the cardiac muscle tissue.
  • the present method and apparatus could have far reaching applications in other forms of surgery.
  • any surgery involving the need to direct therapy from one body cavity towards another adjacent body cavity could be considered.
  • the present invention finds ready applications in the fields of neurosurgery, urology and general vascular surgery.
  • the type of therapy need not be restricted to formation of channels between body cavities.
  • the apparatus and methods described herein are also of use in directing techniques such as catheter ablation, non-contact mapping of heart chambers and the delivery of medicaments to precise areas of the body.

Abstract

Apparutus and methods are described for performing percutancous catheter-based interventional surgery. The apparatus comprises first and second devices that are located in adjacent body cavities, such as adjacent blood vessels, the first device being capable of transmitting a directional signal that can be received by the second device. The direction of the signal is correlated with the facility to direct therapy, such that improved accuracy in therapy placement is thereby achieved. Methods for treating patients utilising the means and apparatus are also provided.

Description

    FIELD OF THE INVENTION
  • The invention relates to apparatus and methods for performing percutaneous catheter-based interventional surgery. In particular, the invention relates to apparatus and techniques for transvascular interstitial surgery.
  • BACKGROUND
  • Minimally invasive surgery, or ‘key-hole’ surgery, allows for surgical devices to be inserted into a patient's body cavity through a small aperture cut. This form of surgery has become increasingly popular as it allows patients treated successfully to suffer less surgical discomfort while retaining the benefits of conventional surgery. Patients treated by such techniques are exposed to lower levels of trauma and their recovery times can be significantly reduced compared to conventional surgical procedures.
  • Key-hole surgery has been adopted as a favoured route for performing laparoscopic surgery as well as in a number of cardiovascular procedures. In the latter case, a balloon catheter may be used to open a partially occluded coronary artery as an alternative to open heart surgery. This technique is known as balloon angioplasty. The balloon catheter is typically a small, hollow, flexible tube that has a balloon near to its distal tip. The catheter is inserted into an artery (usually near the patient's groin) and then guided through the body to the patient's heart. The heart and cardiac arteries are visualized by using X-ray fluoroscopy, and blockages in the heart vessels are identified. A balloon catheter is then inserted in or near the blockage and inflated, thus widening the occluded blood vessel and helping to restore blood flow to the cardiac tissue.
  • However, balloon angioplasty is not always a suitable measure, especially in acute cases and in cases where a coronary artery is completely occluded. In these instances the typical treatment is to employ coronary bypass which involves open-heart surgery. Hence, there is a need to provide new and improved methods and apparatus for use in minimally invasive surgical procedures, such the restoration of a blood supply to ischaemic tissue.
  • Conventional coronary bypass surgery is not always an option for certain patients. Factors such as age, obesity, diabetes and smoking can exclude a proportion of candidate patients who are in genuine need of such treatment. In these cases it has been postulated that minimally invasive surgery could provide a means for treating a broader range of patients including those currently excluded from standard techniques. Oesterle et al (Catheterization and Cardiovascular Interventions (2003) 58: 212-218) describe a technique they call percutaneous in situ coronary venous arterialization (PICVA) which is a catheter based coronary bypass procedure. In PICVA, the occlusion in the diseased artery is ‘bypassed’ by creation of a channel between the coronary artery and the adjacent coronary vein. In this way the arterial blood is diverted into the venous system and can perfuse the cardiac tissue in a retrograde manner (retroperfusion). The technique of retroperfusion has been known for some time, having first been performed in humans by Beck in the 1940s and 1950s (for review see Keelan et al. Current Interventional Cardiology Reports (2000) 2: 11-19). Apparatus and methods for performing procedures like PICVA are described in WO-A-99/49793 and US-A-2004/0133225.
  • However, as the clinical results show in Oesterle et al. (supra), successfully performing a minimally invasive procedure of diverting blood flow from the coronary artery to the adjacent vein has a low success rate. In six out of the 11 cases described this was simply due to an inability to target the adjacent vein from the artery. As such, Oesterle et al's procedure is too often doomed to failure before it even starts. At present, the means for targeting the catheter consist of a combination of X-ray fluoroscopy and an imaging ultrasound probe located on the distal tip of the catheter (e.g. see US-A-2004/0133225). Indeed, such an arrangement is difficult to navigate and localisation of the adjacent vein requires considerable skill on the part of the clinician. Hence, there is a need for improvements in the means for targeting devices, such as catheters, that are used for procedures such as PICVA and in general transvascular surgery. Indeed, in the absence of such improvement it seems that such techniques will remain peripheral to the conventional surgical procedures of open-heart coronary bypass.
  • SUMMARY OF THE INVENTION
  • The present invention provides means, methods and apparatus for overcoming the problems identified in the prior art. Most notably, the means, methods and apparatus of the invention allow for greatly improved targeting and localisation of the therapy to be administered. Hence, the invention shows particular advantage in treating patients requiring coronary bypass by enabling minimally invasive surgical techniques to be used more successfully than previously known.
  • Accordingly, in a first aspect the invention provides a means for directing therapy within the body of a patient, the means comprising:
      • a) a first therapeutic device that is located in a first body cavity, the first therapeutic device comprising signal means for generating a directional signal;
      • b) a second therapeutic device located in a second body cavity adjacent to the first body cavity, the second therapeutic device comprising receiving means for receiving the directional signal; and
      • c) therapeutic means for administering therapy to the body of the patient
        wherein, therapy is directed by aligning the first therapeutic device with the second therapeutic device via the directional signal transmitted by the first therapeutic device being received by the second therapeutic device, and administering therapy at a location that is aligned to the path taken by the directional signal.
  • Optionally the therapeutic means is comprised within either the first or the second therapeutic devices. Typically, the first and second medical devices are catheters. In embodiments of the invention where the first therapeutic device comprises the therapeutic means, the first device is also referred to herein as the ‘launching device’. Likewise, where the second therapeutic device does not comprise the therapeutic means it is, thus, also referred to herein as the ‘target device’.
  • A second aspect of the invention provides means for aligning a first therapeutic device located in a first body cavity with a second therapeutic device located in a second body cavity adjacent to the first body cavity, the means comprising:
      • a) signal means for generating a directional signal, the signal means being located in the first therapeutic device; and
      • b) receiving means for receiving the directional signal, the receiving means being located in the second therapeutic device;
  • wherein, alignment of the first therapeutic device and the second therapeutic device is achieved when the directional signal transmitted by the first therapeutic device is received by the second therapeutic device.
  • A third aspect of the invention provides apparatus for traversing tissue intervening first and second body cavities comprising:
      • a) a launching device suitable for location within the first body cavity, the launching device comprising
        • (i) an elongate outer sheath with a distal end and a proximal end, the outer sheath defining and enclosing an interior lumen;
        • (ii) a signal transducer located at the distal end of the outer sheath, the signal transducer being arranged so as to transmit a directional signal; and
        • (iii) traversing means for traversing the tissue intervening the first and second body cavities, the traversing means being located within the lumen at the distal end of the outer sheath, wherein in use the traversing means is in a retracted state and can be extended out of the lumen via an aperture in the outer sheath such that it engages and traverses the tissue intervening the first and second body cavities, and wherein extension of the traversing means is along a path that is aligned with the direction of the signal;
      • and,
      • b) a target device suitable for location within the second body cavity, the target device comprising
        • (i) an elongate outer sheath with a distal end and a proximal end, the outer sheath defining and enclosing an interior lumen; and
        • (ii) a signal receiving transducer located at the distal end of the outer sheath;
  • wherein, in use, the signal transducer on the launching device transmits the directional signal that is capable of being received by the signal receiving transducer on the target device, and
  • when the signal is received by the signal receiving transducer on target device it is determined that the devices are located in the correct juxtaposition within their respective body cavities such that the traversing means can be extended out of the launching device and traverses the tissue intervening the first and second body cavities.
  • A fourth aspect of the invention provides a method for directing therapy in the body of a patient, comprising:
      • a) placing a first therapeutic device into a first body cavity, the first therapeutic device comprising signal means for generating a directional signal, and therapeutic means for administering therapy to the body of the patient; and
      • b) placing a second therapeutic device into a second body cavity that is adjacent to the first body cavity, the second therapeutic device comprising receiving means for receiving the directional signal;
  • wherein, therapy is directed by aligning the first therapeutic device with the second therapeutic device via the directional signal transmitted by the first therapeutic device being received by the second therapeutic device, and administering therapy at a location that is aligned to the path taken by the directional signal.
  • In a particular embodiment of the invention the step of administering therapy comprises creation of an aperture in tissue between the first and second body cavities, thereby allowing fluid communication between the first and second body cavities. In accordance with the invention, the aperture is created at a position that lies along the path taken by the directional signal.
  • All references cited herein are incorporated by reference in their entirety. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
  • The invention is further illustrated by reference to the accompanying drawings in which:
  • FIG. 1 is a representation of an embodiment of the invention in which the launching device directs a signal from a first body cavity to the target device located in an adjacent second body cavity;
  • FIG. 2 is a cross sectional representation along the line of BB in FIG. 1;
  • FIG. 3 is a representation of a specific embodiment of the launching device of the invention;
  • FIG. 4 is a representation of a specific embodiment of the target device of the invention. Arrow A shows the reversed direction of blood flow after an arterial-venous stenosis (also called PICVA) has been effected;
  • FIG. 5 is a representation of a specific embodiment of the launching device of the invention in which the signal transducer is comprised of an array of signal transducer elements;
  • FIG. 6 is a representation of an embodiment of the invention wherein the launching and target devices comprise centring means;
  • FIG. 7 is a representation of a stent in place following a procedure such as arterial-venous stenosis. Interrupted arrow A shows the direction of blood flow through the stent between the first and second body cavities.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In the embodiment of the invention as shown in FIG. 1, there is provided a launching device (10), which comprises a signal transmitter (12). The launching device (10) is typically a catheter that consists of an elongate flexible rod-like portion and a tip portion, and which provides a conduit for administering therapy within the body of a patient. Hence, the launching device (10) is suitable for location and movement through a first cavity or vessel (30) within a patient's body. The elongate portion of the launching device (10) comprises an outer sheath (11) that encloses a space, defining a lumen (13). The space within the lumen (13) may be suitably partitioned or subdivided as necessary so as to define channels for administering therapy or controlling the positioning of the launching device (10). Such subdivision may, for instance, be achieved either longitudinally or concentrically in an axial fashion.
  • A signal transducer (12) is located on the launching device (10). The signal transducer (12) provides a signal (40) that is directed outwards from the first launching device (10). In the embodiment shown in FIG. 1 the signal (40) is directed radially outward from the launching device (10) in a direction that is perpendicular to the longitudinal axis of the launching device (10). As mentioned in greater detail below, in alternative embodiments of the invention the direction of the signal (40) need not be perpendicular and can be directed at an angle to that of the axis of the launching device (10). The signal transducer (12) is, thus, comprised within the signal generating means of the apparatus of the invention.
  • The signal transducer (12) is connected to signal transmitter (50). The signal transmitted can be suitably selected from ultrasound or appropriate electromagnetic sources such as a laser, microwave radiation or via radio waves. In a specific embodiment of the invention described in further detail below, the signal transmitter (50) generates an ultrasound signal, which is relayed to the signal transducer (12), which in turn directs the signal (40) out of the body cavity (30) into the surrounding tissue.
  • According to the invention, a second device is located within an adjacent second body cavity or vessel (32). The first and second body cavities (30 and 32 respectively) are separated by intervening tissue (34), sometimes referred to as interstitial tissue or a septum. The first and second body cavities (30, 32) are located next to each other in a parallel fashion for at least a portion of their respective lengths. For example, many of the veins and arteries of the body are known to run in parallel with each other for at least a portion of their overall length.
  • The second device is the target device (20), which assumes a similar arrangement to that of the first device (10). The target device (20) can also be a catheter that consists of an elongate flexible rod-like portion and a tip portion, such that fine movement and positioning of the target device (20) within the body cavity (32) can be achieved. In common with the launching device (10) the target device (20) comprises an outer sheath (21) that encloses a space, defining a lumen (23). The lumen (23) can be suitably partitioned as with the launching device (10).
  • The target device (20) comprises a receiving transducer (22) for receiving the signal (40). The receiving transducer (22) is comprised within the signal detection means of the apparatus of the invention. In use, when the receiving transducer (22) receives the signal (40) transmitted from signal transducer (12), it transmits the received signal to signal detector (60). The signal detector (60) provides an output reading to the user of the apparatus via output display (61).
  • In this way, the transmission and detection of the directed signal (40) allows for the navigation and positioning of the launching device (10) relative to the target device (20). In use, the launching device (10) and target device (20) can be maneuvered by the user of the apparatus until the output display (61) indicates that signal (40) is being received by the target device (40).
  • In a specific embodiment of the invention, the signal (40) is an ultrasound signal. The signal (40) is directional and is emitted by the signal transducer (12) in shape of a narrow cone or arc—i.e. with the width of the signal band increasing as the distance from the signal transducer (12) increases. Hence, the precision of alignment between the launching device (10) and the target device (20) depends not only upon signal detection but also upon the distance between the two devices, as at greater distances the signal bandwidth is also greater. This level of error is referred to as ‘positional uncertainty’. It will be appreciated that a certain level of tolerance exists for positional uncertainty, however, if therapy is to be directed with precision the amount of uncertainty should be minimised. For example, if the diameter (d) of the signal transducer (12) is 1 mm and the frequency of the ultrasound signal is 30 MHz, then the positional uncertainty (x)—i.e. the margin of error on either side of a centre line—will be 1 mm at a perpendicular separation of 5 mm between the launching and target devices (10, 20). For clinical applications of the invention, it is preferred that the positional uncertainty does not exceed around +/−5 mm (that is a total signal bandwidth of 10 mm at the point reception). More preferably, the positional uncertainty should be between around +/−0.01 mm and around +/−4.50 mm. Even more preferably, the positional uncertainty should be between around +/−0.1 mm and around ±2 mm. Ideally, the positional uncertainty does not exceed around +/−1 mm.
  • The strength of the signal (40) will also be a determining factor and it will be appreciated that signal strength will diminish significantly as the distance between the launching device (10) and the target device (20) increases. This distance is in part determined by the amount of intervening tissue (34) between the two devices. By way of example, if the signal (40) is an ultrasound signal, it can be expected that significant deterioration of signal will occur where the launching device (10) and the target device (20) a separated by more than around 20 mm of solid tissue. Obviously, the density of the intervening tissue (34) will also have an effect upon the deterioration of signal (40) over distance.
  • The frequency of the desired ultrasound signal also determines the thickness of the signal transducer, which for a standard ultrasound ceramic transducer—such as a PZT—will be 0.075 mm at 30 MHz.
  • FIG. 2 shows a cross sectional view of the arrangement in FIG. 1, along the line BB. The correct orientation of the launching device relative to the target device is an important factor as it is this line of orientation (41) that determines where the therapy is to be applied. It will be understood by the skilled addressee that the clinical need for precisional placing of therapy in a patient necessitates a requirement for a directional signal (40) that is linked to the means for delivering therapy. In this way, the user of the apparatus of the invention can administer therapy to the correct location by ensuring that the launching device (10) and the target device (20) are correctly positioned via transmission and reception of the signal (40). Hence, the orientation line (41) denotes not only the direction of signal travel but also the path along which therapy can be administered to the patient.
  • An embodiment of the invention is shown in FIG. 3 in which the signal transducer (120) is oriented at an oblique angle relative to the longitudinal axis of the launching device (10). Hence, the signal (40) is transmitted at an angle that is in the direction of forward travel of the launching device (10) as it enters a body cavity (30). The preferred signal beam angle is between around 20° and around 60° to the perpendicular, more preferably between around 30° and around 50° to the perpendicular, and most preferably around 45° to the perpendicular, when 0° corresponds to the longitudinal axis of the launching device in the direction of travel.
  • The launching device (10) in FIG. 2, also shows an embodiment of the invention in which one means for administering therapy is provided. Launching device (10) comprises a hollow needle or cannula (17). The hollow needle (17) is located in an undeployed or retracted state within the lumen (13) of launching device (10). The hollow needle (17) may be deployed/extended from the launching device (10) at a time deemed appropriate by the user of the apparatus, via an aperture (16) in the outer sheath (11), The aperture (16), thus, can allow communication between the lumen (13) and the body cavity (30). It should be noted that the hollow needle (17) preferably travels along a path that is parallel to the direction of the signal (40) and is used to pierce the intervening tissue (34). In a preferred embodiment of the invention, the hollow needle makes a transit across the entirety of the intervening tissue (34) and in doing so allows the launching device (10) to access the second body cavity (32). If desired, the pathway made by the hollow needle (17) through the intervening tissue (34) can be subsequently widened to allow fluid communication between the first body cavity (30) and the second body cavity (32).
  • Therapeutic means suitable for use in the invention can comprise devices or instruments selected from the group consisting of a cannula; a laser; a radiation-emitting device; a probe; a drill; a blade; a wire; a needle and appropriate combinations thereof.
  • In a specific embodiment of the invention, the hollow needle (17) comprises a sensor (19) so as to assist further in determining positional information of the tip of the hollow needle relative to the launching device. In another specific embodiment of the invention the sensor (19) is capable of detecting changes in hydrostatic pressure. Other sensors that are suitable for use in the apparatus and methods of the invention can include temperature sensors, oxygenation sensors and/or colour sensors
  • Optionally, the hollow needle can further comprise an additional signal transducer (122). In the embodiment shown in FIG. 3 the signal transducer (122) is located near the tip of the hollow needle on the end of a guide wire (14). However, the signal transducer (122) can easily be located on the hollow needle if this is preferred. In use, the signal transducer (122) is driven with a short transmit pulse which produces a non-directional signal pulse. The signal pulse can be detected by the receiving transducer (23) mounted on the target device (20). From the time delay between the transmit pulse to the receipt of the signal pulse on the receiving transducer (23) the distance from the incoming guide wire (14) or hollow needle (17) to the receiving transducer (23) and hence the target device (20), can be determined.
  • As mentioned above, the target device (20) comprises a receiving transducer (22) for receiving the signal (40). The receiving transducer (22) can be unidirectional—i.e. capable of receiving a signal from one direction only—or omnidirectional—i.e. capable of receiving a signal from any direction. In the embodiment of the invention shown in FIG. 4, a target device (20) is located within a body cavity (32). The target device (20) comprises an omnidirectional ultrasound signal receiving transducer. A reflecting cone (601) directs the signal (40) onto a disc-shaped receiving transducer (60). An acoustically transparent window (602) separates the reflecting cone (601) from the receiving transducer (60). In an alternative embodiment, an omnidirectional ultrasound signal receiving transducer can be obtained by locating cylinder of a flexible piezoelectric material such as PVDF (polyvinyldifluoride) around the outer sheath of the target device (20). In such a way the cylinder acts in an equivalent manner to the receiving transducer (60).
  • FIG. 4 also shows an embodiment of the invention in which the target device (20) comprises a channel (25) for administering an agent, such as a therapeutic agent, to a patient. In a specific embodiment, the channel (25) functions as a conduit to allow application of a blocking material (251) that serves to obstruct or occlude the body cavity (32). The blocking material (251) can be suitably selected from a gel based substance. The placement of the blocking material (251) can be directed by movement of the target device (20). The presence of a guide member (24) within the lumen (23) of the target device (20) allows the user of the apparatus to precisely manipulate the position of the target device (20) as required. Alternative blocking materials (251) can include embolisation members (such as balloons) and self-expanding stents, for example.
  • The launching device (10) comprises a signal transducer (12) that is optionally oriented so that the signal (40) is transmitted at an angle as shown in FIG. 2. In an alternative embodiment of the invention, shown in FIG. 5, the signal transducer is in the form of a signal transducer array (123). The signal transducer array (123) comprises a plurality of signal transducer elements (124) which can be oriented collectively and thereby define the signal beam width and angle relative to the launching device (10). A further advantage of the embodiment shown in FIG. 5, is that the smaller size of the elements (124) means that the signal transducer does not occupy a significant proportion the lumen (13) of the launching device (10).
  • The embodiment in FIG. 5 is particularly suited to ultrasound beam-forming signalling. FIG. 5 shows an array of signal transducer elements (124) that are separately connected to the transmitter (50) via delays (51) so that the signals to each element are delayed relative to each other. The delays ensure that the ultrasound wavefronts from each element are aligned to produce a beam of ultrasound (40) at the requisite angle. In an alternative embodiment where the signal (40) is in the form of visible light, an array of LEDs can be used.
  • To assist in the process of alignment between the launching device (10) in the first body cavity (30) and the target device (20) in the second body cavity (32), a further embodiment of the invention provides for the devices to comprise means for centring the respective devices within the body cavities. In one embodiment the centring means comprises an inflatable bladder or balloon (111) which is located in the lumen (13, 23) when in an undeployed state and, when the device (10, 20) reaches the desired location within the patient, can be inflated. The balloon (111) can be annular in shape such that is surrounds the device (10, 20) in a doughnut-like fashion. The balloon (111) can also be arranged such that it inflates on only one or on two opposite sides of the device. In FIG. 6, an embodiment of the invention is shown where the balloon (111) is shown deploying on one side of the launching device (10).
  • Alternatively, in a further embodiment, the centring means is comprised of one or more loop structures (211). In this embodiment, the one or more loop structures (211) are located either in the lumen (13, 23) or within recesses made in the outer sheath (11, 21) when in an undeployed or retracted state. Hence, when the device (10, 20) reaches the desired location within the patient, the one or more loop structures (211) can be expanded outwardly from the device (10, 20), thereby, centring the device (10, 20) within the body cavity (30, 32). Outward expansion of the loop structures (211) can be suitably effected by compression of a length of wire, for example, such that it bows outwardly from the outer sheath (11, 21). A centring device that adopts this conformation typically comprises a plurality of compressible lengths of wire, or other suitable flexible material, arranged in parallel at radially spaced intervals around the periphery of the outer sheath (11, 21). Compression of the plurality of wires can be induced by way of a sliding member (not shown) located proximally and/or distally near to the ends of the plurality of wires. The sliding member is capable of translational movement along the longitudinal axis of the device (10, 20).
  • In FIG. 6, an embodiment of the invention is shown where the target device (20) comprises fully deployed centring means (211) that has allowed the target device (20) to be centred within the body cavity (32). Arrangements for centring the devices within the body cavities include, but are not limited to, expandable Chinese-lantern type devices, reversibly expandable stents, coils, helices and retractable probes or legs.
  • The invention is further illustrated by the following non-limiting example.
  • EXAMPLE
  • The methods and apparatus of the present invention demonstrate particular utility in cardio-vascular surgery. In the present example the apparatus of the invention is used by a clinician to perform the procedure of arterial-venous stenosis (PICVA) so as to enable retroperfusion of cardiac tissue following occlusion of a coronary artery.
  • The launching catheter (10) is inserted into the occluded coronary artery by standard keyhole surgical techniques. Likewise, the target catheter (20) is inserted into the coronary vein that runs parallel to the coronary artery. The coronary vein is not occluded and, therefore, provides an alternative channel for blood flow to the cardiac muscle effectively allowing the occlusion in the coronary artery to be bypassed.
  • The launching catheter (10) comprises a PZT ultrasound transducer (12) (CTS Piezoelectric Products, Albuquerque, N. Mex.) that is oriented such that a directional ultrasound beam is transmitted at a 45° angle (relative to the longitudinal axis of the launching device) in the direction of blood flow in the artery. The ultrasound transducer (12) is activated and a 30 MHz directional ultrasound signal (40) is transmitted from the launching catheter (10). The target catheter (20) comprises an omnidirectional ultrasound receiving transducer (60). To assist with localisation of both the launching and target catheters (10, 20), both catheters comprise centring means in the form of an annular inflatable balloon (111). The centring means on the launching catheter (10) is deployed by the clinician when the launching catheter (10) is deemed to be in an appropriate location close to the site of the occlusion within the coronary artery. This is typically determined via standard fluoroscopic imaging techniques. The target catheter (20) is then moved within the adjacent coronary vein until the directed ultrasound signal (40) is detected by the signal receiving transducer (60). To enable more precise alignment between the launching and target catheters (10, 20) the centring means (111) on the target catheter (20) can be deployed either before or after the signal (40) is detected.
  • On reception of the transmitted signal (40) the clinician can be certain that the launching and target catheters (10, 20) are correctly located within their respective blood vessels to allow for the arterial-venous stenosis procedure to commence. The target catheter (20) is used to block blood flow within the coronary vein via administration of a gel blocking material (251) though a channel (25) in the target catheter (10). The blocking material (251) is administered at a position downstream in terms of the venous blood flow relative to the location of the receiving signal transducer (60).
  • The clinician is then able to initiate arterial-venous stenosis by deploying a hollow needle (17) from the launching catheter (10) substantially along a path that is parallel and close to that taken by the ultrasound signal (40) though the intervening tissue (34) between the coronary artery and the coronary vein. The hollow needle (17) comprises a sensor means (19) near its tip that detects changes in hydrostatic pressure. Hence, the clinician is able to monitor the transition from arterial pressure to venous pressure as the hollow needle passes between the two vessels. The hollow needle (17) further comprises a guide member (14) in the form of a wire located in the bore of the needle. Once the hollow needle has been passed across the intervening tissue (34) it is retracted leaving the guide wire (14) in place. Alternatively, once the hollow needle (17) has made the transition across the intervening tissue (34) the clinician is able to pass the guide wire (14) through the bore of the needle and then retract the needle (17) into the launching catheter (10).
  • The clinician withdraws the launching catheter (10) from the patient leaving the guide wire (14) in place. A further catheter device is then slid along the guide wire (14) and an expandable stent (26) is deployed in order to widen the perforation in the intervening tissue (34) between the coronary artery and vein (see FIG. 7). The target catheter (20) is withdrawn from the patient leaving the blocking material (251) in position. Optionally, a further block or suture may be inserted into the coronary vein prevent reversal of arterial blood flow.
  • Hence, arterial blood is thereby diverted into the venous system and is enabled to retroperfuse the cardiac muscle tissue.
  • Whilst the specific example described above is restricted to the field of cardio-vascular surgery, it is envisaged that the present method and apparatus could have far reaching applications in other forms of surgery. For example, any surgery involving the need to direct therapy from one body cavity towards another adjacent body cavity could be considered. Hence, the present invention finds ready applications in the fields of neurosurgery, urology and general vascular surgery. In addition the type of therapy need not be restricted to formation of channels between body cavities. For instance, the apparatus and methods described herein are also of use in directing techniques such as catheter ablation, non-contact mapping of heart chambers and the delivery of medicaments to precise areas of the body.
  • Although particular embodiments of the invention have been disclosed herein in detail, this has been done by way of example and for the purposes of illustration only. The aforementioned embodiments are not intended to be limiting with respect to the scope of the appended claims, which follow. It is contemplated by the inventors that various substitutions, alterations, and modifications may be made to the invention without departing from the spirit and scope of the invention as defined by the claims.
  • NUMERALS USED IN THE FIGURES
  • 10 Launching device
    11 Outer sheath
    111 Centring device
    12 Signal transducer
    120 Angled signal transducer
    122 Needle mounted signal transducer
    123 Signal transducer array
    124 Signal transducer element
    13 Lumen
    14 Guide means
    16 Aperture
    17 Hollow needle
    19 Pressure sensor
    20 Target device
    21 Outer sheath
    211 Centring device
    22 Receiving transducer
    23 Lumen
    24 Guide member
    25 Channel
    251 Blocking material
    26 Stent
    30 First body cavity
    32 Second body cavity
    34 Intervening tissue
    40 Signal
    41 Orientation direction
    50 Signal transmitter
    51 Transmitter delay
    60 Signal detector
    601 Reflecting cone
    602 window
    61 Output display

Claims (51)

1-48. (canceled)
49. Apparatus for directing therapy within the body of a patient, the apparatus comprising:
a) a first therapeutic device that is locatable within the lumen of a first body cavity, the first therapeutic device comprising elongate body upon which is located a signal transmitter for generating a directional signal;
b) a second therapeutic device that is locatable within the lumen of a second body cavity adjacent to the first body cavity, the second therapeutic device comprising an elongate body upon which is located a receiver for receiving the directional signal; and
c) a therapeutic member for administering therapy to the body of the patient
wherein, therapy is directed by aligning the first therapeutic device with the second therapeutic device via the directional signal transmitted from the signal transmitter located on first therapeutic device, which is received by the receiver located on the second therapeutic device, and administering therapy at a location that is aligned to the path taken by the directional signal.
50. The apparatus of claim 49, wherein the therapeutic member is comprised within the elongate body of the first therapeutic device.
51. The apparatus of claim 49, wherein the therapeutic member is comprised within the elongate body of the first therapeutic device and can be retractably deployed therefrom.
52. The apparatus of claim 49, wherein the therapeutic member is comprised within the elongate body of the second therapeutic device.
53. The apparatus of claim 49, wherein the therapeutic member is comprised within the elongate body of the second therapeutic device and can be retractably deployed therefrom.
54. The apparatus of claim 49, wherein the directional signal is selected from the group consisting of: ultrasound; laser radiation; a radio signal; microwave radiation; and other electromagnetic radiation.
55. The apparatus of claim 49, wherein the signal transmitter comprises a signal transducer.
56. The apparatus of claim 49, wherein the signal transmitter comprises an ultrasound signal transducer.
57. The apparatus of claim 49, wherein the signal transmitter comprises an array of transducer elements.
58. The apparatus of claim 49, wherein the receiver comprises a receiving transducer.
59. The apparatus of claim 49, wherein the receiver comprises an ultrasound receiving transducer.
60. The apparatus of claim 49, wherein the receiver comprises a receiving transducer that is an omnidirectional receiver.
61. The apparatus of claim 49, wherein the directional signal is directed at an angle perpendicular to a longitudinal axis of the elongate body of first therapeutic device.
62. The apparatus of claim 49, wherein the directional signal is directed at an oblique angle relative a longitudinal axis of the elongate body of the first therapeutic device.
63. The apparatus of claim 49, wherein the directional signal is directed at an oblique angle relative a longitudinal axis of the elongate body of the first therapeutic device and wherein the oblique angle is preferably between around 20° and around 60° to the perpendicular, more preferably between around 30° and around 50° to the perpendicular, and most preferably around 45° to the perpendicular, when 0° corresponds to the longitudinal axis of the elongate body of the first therapeutic device.
64. The apparatus of claim 49, wherein the first and second therapeutic devices are catheters.
65. The apparatus of claim 49, wherein the therapeutic member comprises a device selected from the group consisting of: a cannula; a laser; a radiation-emitting device; a probe; a drill; a blade; a wire; a needle; and combinations thereof.
66. The apparatus of claim 49, wherein the therapeutic member further comprises one or more sensors.
67. The apparatus of claim 49, wherein the therapeutic member further comprises a pressure sensor.
68. The apparatus of claim 49, wherein the therapeutic member further comprises a signal transmitter.
69. The apparatus of claim 49, wherein the therapeutic member further comprises a ultrasound transmitter.
70. The apparatus of claim 49, wherein the first and second body cavities are blood vessels.
71. The apparatus of claim 49, wherein the first body cavity is an artery and the second body cavity is a vein.
72. The apparatus of claim 49, wherein the first body cavity is a vein and the second body cavity is an artery.
73. The apparatus of claim 49, wherein the elongate body of the first therapeutic device further comprises at least one centering member, for centering the first therapeutic device within the lumen of the first body cavity, wherein the at least one centering member comprises a device selected from the group consisting of: a bladder; a balloon; a looped structure; a wire; a probe; a leg; a coil; a helix; and an expandable stent.
74. The apparatus of claim 49, wherein the elongate body of the second therapeutic device further comprises at least one centering member, for centering the second therapeutic device within the lumen of the second body cavity wherein the at least one centering member comprises a device selected from the group consisting of: a bladder; a balloon; a looped structure; a wire; a probe; a leg; a coil; a helix; and an expandable stent.
75. The apparatus of claim 49, wherein the first therapeutic device further comprises at least one centering member in the form of an annular balloon which encircles the elongate body of the first therapeutic device and that can be expanded radially outwardly therfrom, thereby centering the first therapeutic device within the lumen of the first body cavity.
76. The apparatus of claim 49, wherein the second therapeutic device further comprises at least one centering member in the form of an annular balloon which encircles the elongate body of the second therapeutic device and that can be expanded radially outwardly therfrom, thereby centering the second therapeutic device within the lumen of the second body cavity.
77. The apparatus of claim 49, wherein the first therapeutic device further comprises at least one centering member in the form of a plurality of flexible members arranged in parallel at intervals around the periphery of the elongate body of the first therapeutic device, wherein compression of the plurality of flexible members can be effected by way of a ring slidably located on the elongate body at a position adjacent to the ends of the plurality of flexible members, the sliding member being capable of translational movement along the longitudinal axis of the elongate body, and wherein the ring allows a compressive force to be applied to the plurality of flexible members thereby causing the flexible members bow outwardly relative to the elongate body of the first therapeutic device.
78. The apparatus of claim 49, wherein the second therapeutic device further comprises at least one centering member in the form of a plurality of flexible members arranged in parallel at intervals around the periphery of the elongate body of the second therapeutic device, wherein compression of the plurality of flexible members can be effected by way of a ring slidably located on the elongate body at a position adjacent to the ends of the plurality of flexible members, the sliding member being capable of translational movement along the longitudinal axis of the elongate body, and wherein the ring allows a compressive force to be applied to the plurality of flexible members thereby causing the flexible members bow outwardly relative to the elongate body of the second therapeutic device.
79. A method for aligning a first therapeutic device, having an elongate body, located within the lumen of a first body cavity with a second therapeutic device, having an elongate body, located within the lumen of a second body cavity that is adjacent to the first body cavity, the method comprising:
a) locating a signal transmitter on the elongate body of the first therapeutic device, wherein the signal transmitter is capable of generating a directional signal; and
b) locating a receiver on the elongate body of the second therapeutic device, wherein the receiver is for receiving the directional signal;
wherein, alignment of the first therapeutic device and the second therapeutic device in their respective first and second body cavities is achieved when the directional signal transmitted from the transmitter on the first therapeutic device is received by the receiver on the second therapeutic device.
80. The method of claim 79, wherein the directional signal is selected from the group consisting of: ultrasound; laser radiation; a radio signal; microwave radiation; and other electromagnetic radiation.
81. The method of claim 79, wherein the signal transmitter comprises a signal transducer.
82. The method of claim 79, wherein the signal transmitter comprises an ultrasound transducer.
83. The method of claim 79, wherein the signal transmitter comprises an array of signal transducer elements.
84. The method of claim 79, wherein the receiver comprises a receiving transducer.
85. The method of claim 79, wherein the receiver comprises an ultrasound receiving transducer.
86. The method of claim 79, wherein the receiver comprises an omnidirectional receiving transducer.
87. The method of claim 79, wherein the directional signal is directed at an angle perpendicular to a longitudinal axis of the elongate body of the first therapeutic device.
88. The method of claim 79, wherein the directional signal is directed at an oblique angle relative a longitudinal axis of the elongate body of the first therapeutic device, and wherein the oblique angle is preferably between around 20° and around 60° to the perpendicular, more preferably between around 30° and around 50° to the perpendicular, and most preferably around 45° to the perpendicular, when 0° corresponds to the longitudinal axis of the elongate body of the first therapeutic device.
89. The method of claim 79, wherein the first and second therapeutic devices are catheters.
90. Apparatus for traversing tissue intervening first and second anatomical cavities within the body of an animal, comprising:
a) a launching device suitable for location within the first anatomical cavity, the launching device comprising
(i) an elongate outer sheath with a distal end and a proximal end, the outer sheath defining and enclosing an interior lumen;
(ii) a signal transducer located at the distal end of the outer sheath, the signal transducer being arranged so as to transmit a directional signal; and
(iii) traversing member for traversing the tissue intervening the first and second body cavities, the traversing member being located within the lumen at the distal end of the outer sheath, wherein in use the traversing member is in a retracted state and can be extended out of the lumen via an aperture in the outer sheath such that it engages and traverses the tissue intervening the first and second anatomical cavities, and wherein extension of the traversing means is along a path that is aligned with the direction of the signal; and,
b) a target device suitable for location within the second anatomical cavity, the target device comprising
(i) an elongate outer sheath with a distal end and a proximal end, the outer sheath defining and enclosing an interior lumen; and
(ii) a signal receiving transducer located at the distal end of the outer sheath;
(iii) wherein, in use, the signal transducer on the launching device transmits the directional signal that is capable of being received by the signal receiving transducer on the target device, and
when the signal is received by the signal receiving transducer on target device it is determined that the devices are located in the correct juxtaposition within their respective anatomical cavities such that the traversing member can be extended out of the launching device and traverses the tissue intervening the first and second anatomical cavities.
91. The apparatus of claim 90, wherein the directional signal is selected from the group consisting of ultrasound, laser radiation, a radio signal, microwave radiation and other electromagnetic radiation.
92. The apparatus of claim 90, wherein the directional signal is directed at an angle perpendicular to a longitudinal axis of the launching device.
93. The apparatus of claim 90, wherein the directional signal is directed at an oblique angle relative a longitudinal axis of the launching device and wherein the oblique angle is preferably between around 20° and around 60° to the perpendicular, more preferably between around 30° and around 50° to the perpendicular, and most preferably around 45° to the perpendicular, when 0° corresponds to the longitudinal axis of the launching device.
94. The apparatus of claim 90, wherein the traversing member comprises a device selected from the group consisting of a cannula; a laser; a radiation-emitting device; a probe; a drill; a blade; a wire; a needle and combinations thereof.
95. The apparatus of claim 90, wherein the traversing member traverses the tissue intervening the first and second anatomical cavities along a path that is aligned to the path taken by the directional signal.
96. The apparatus of claim 90, wherein the animal is a human.
97. A method for directing therapy in the body of a patient, comprising:
a) placing a first therapeutic device into a first body cavity, the first therapeutic device comprising signal means for generating a directional signal, and therapeutic means for administering therapy to the body of the patient; and
b) placing a second therapeutic device into a second body cavity that is adjacent to the first body cavity, the second therapeutic device comprising receiving means for receiving the directional signal;
wherein, therapy is directed by aligning the first therapeutic device with the second therapeutic device via the directional signal transmitted by the first therapeutic device being received by the second therapeutic device, and administering therapy at a location that intersects the path taken by the directional signal.
98. The method of claim 97, wherein the step of administering therapy comprises creation of an aperture in tissue between the first and second body cavities, thereby allowing fluid communication between the first and second body cavities.
US11/662,128 2004-09-08 2005-09-08 Minimally Invasive Surgical Appartus and Methods Abandoned US20080194939A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0419954.3A GB0419954D0 (en) 2004-09-08 2004-09-08 System for directing therapy
GB0419954.3 2004-09-08
PCT/GB2005/003480 WO2006027599A1 (en) 2004-09-08 2005-09-08 Minimally invasive surgical apparatus and methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/003480 A-371-Of-International WO2006027599A1 (en) 2004-09-08 2005-09-08 Minimally invasive surgical apparatus and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/141,913 Continuation US10398580B2 (en) 2004-09-08 2013-12-27 Minimally invasive surgical apparatus and methods

Publications (1)

Publication Number Publication Date
US20080194939A1 true US20080194939A1 (en) 2008-08-14

Family

ID=33186680

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/662,128 Abandoned US20080194939A1 (en) 2004-09-08 2005-09-08 Minimally Invasive Surgical Appartus and Methods
US14/141,913 Active 2028-04-04 US10398580B2 (en) 2004-09-08 2013-12-27 Minimally invasive surgical apparatus and methods
US16/552,168 Active 2026-10-16 US11446170B2 (en) 2004-09-08 2019-08-27 Minimally invasive surgical apparatus and methods

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/141,913 Active 2028-04-04 US10398580B2 (en) 2004-09-08 2013-12-27 Minimally invasive surgical apparatus and methods
US16/552,168 Active 2026-10-16 US11446170B2 (en) 2004-09-08 2019-08-27 Minimally invasive surgical apparatus and methods

Country Status (4)

Country Link
US (3) US20080194939A1 (en)
EP (1) EP1796549B1 (en)
GB (1) GB0419954D0 (en)
WO (1) WO2006027599A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130035758A1 (en) * 2008-04-18 2013-02-07 Medtronic Corevalve Llc Apparatus for Treating a Heart Valve, In Particular a Mitral Valve
US9108018B2 (en) 2006-04-20 2015-08-18 Limflow Gmbh Methods for fluid flow through body passages
US9314329B2 (en) 2013-03-08 2016-04-19 Limflow Gmbh Methods and systems for providing or maintaining fluid flow through body passages
WO2016141281A1 (en) * 2015-03-04 2016-09-09 Indiana University Research & Technology Corporation Ultrasound catheter
US9545263B2 (en) * 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
JP2018508333A (en) * 2015-03-10 2018-03-29 ステント・テック・リミテッドStent Tek Limited Surgical system, surgical device, and surgical system and method of using the surgical device for percutaneous creation of a self-vascular use subcutaneous arteriovenous fistula (AVF)
JP2018126555A (en) * 2010-11-16 2018-08-16 ティーブイエー メディカル, インコーポレイテッド Devices and methods for forming fistula
US10398580B2 (en) 2004-09-08 2019-09-03 Limflow Gmbh Minimally invasive surgical apparatus and methods
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US10835367B2 (en) 2013-03-08 2020-11-17 Limflow Gmbh Devices for fluid flow through body passages
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130346B2 (en) * 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
EP3169249B1 (en) 2014-07-15 2018-11-28 Koninklijke Philips N.V. Devices for intrahepatic shunts
EP3538192A4 (en) * 2016-11-11 2020-09-30 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement

Citations (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US625116A (en) * 1899-05-16 Edouard martin
US4249539A (en) * 1979-02-09 1981-02-10 Technicare Corporation Ultrasound needle tip localization system
US5397339A (en) * 1986-11-14 1995-03-14 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US5443497A (en) * 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US5655548A (en) * 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6015405A (en) * 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6068638A (en) * 1995-10-13 2000-05-30 Transvascular, Inc. Device, system and method for interstitial transvascular intervention
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6099542A (en) * 1996-03-15 2000-08-08 Beth Israel Hospital Association Inc. Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a prechosen anatomic site in-vivo
US6186972B1 (en) * 1996-09-16 2001-02-13 James A. Nelson Methods and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6206912B1 (en) * 1996-11-07 2001-03-27 St. Jude Medical Anastomotic Technology Group Inc. Medical grafting methods and apparatus
US6217527B1 (en) * 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6231546B1 (en) * 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
US6241744B1 (en) * 1998-08-14 2001-06-05 Fox Hollow Technologies, Inc. Apparatus for deploying a guidewire across a complex lesion
US6280388B1 (en) * 1997-11-19 2001-08-28 Boston Scientific Technology, Inc. Aerogel backed ultrasound transducer
US6375615B1 (en) * 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6379319B1 (en) * 1996-10-11 2002-04-30 Transvascular, Inc. Systems and methods for directing and snaring guidewires
US20020068869A1 (en) * 2000-06-27 2002-06-06 Axel Brisken Drug delivery catheter with internal ultrasound receiver
US20020089262A1 (en) * 2000-05-09 2002-07-11 Minoru Topa Cylindrical transducer apparatus
US6432127B1 (en) * 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US6475226B1 (en) * 1999-02-03 2002-11-05 Scimed Life Systems, Inc. Percutaneous bypass apparatus and method
US6508824B1 (en) * 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US6511491B2 (en) * 1999-03-09 2003-01-28 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6517558B2 (en) * 1999-01-15 2003-02-11 Ventrica, Inc. Methods and devices for forming vascular anastomoses
US6544230B1 (en) * 1998-03-31 2003-04-08 Transvascular, Inc. Catheters, systems and methods for percutaneous in situ arterio-venous bypass
US6561998B1 (en) * 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US6569145B1 (en) * 1999-03-25 2003-05-27 Transvascular, Inc. Pressure-controlled continuous coronary sinus occlusion device and methods of use
US6579311B1 (en) * 1996-02-02 2003-06-17 Transvascular, Inc. Method for interstitial transvascular intervention
US6589164B1 (en) * 2000-02-15 2003-07-08 Transvascular, Inc. Sterility barriers for insertion of non-sterile apparatus into catheters or other medical devices
US6602241B2 (en) * 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US6610087B1 (en) * 1999-11-16 2003-08-26 Scimed Life Systems, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US6685716B1 (en) * 2000-01-04 2004-02-03 Transvascular, Inc. Over-the-wire apparatus and method for open surgery making of fluid connection between two neighboring vessels
US6685648B2 (en) * 1996-10-11 2004-02-03 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6709444B1 (en) * 1996-02-02 2004-03-23 Transvascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US6711429B1 (en) * 1998-09-24 2004-03-23 Super Dimension Ltd. System and method for determining the location of a catheter during an intra-body medical procedure
US6719781B1 (en) * 1996-06-14 2004-04-13 Aptus Medical Inc. Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US20040097990A1 (en) * 1999-01-27 2004-05-20 Zhao Iris Ginron Graft material, device & method of making
US6746426B1 (en) * 2000-07-11 2004-06-08 Medtronic Vascular, Inc. Transluminally deliverable vascular blockers and methods for facilitating retrograde flow of arterial blood through veins
US20050038501A1 (en) * 2003-08-12 2005-02-17 Moore James E. Dynamic stent
US6858037B2 (en) * 1996-03-05 2005-02-22 Evysio Medical Devices Ulc Expandable stent and method for delivery of same
US6863684B2 (en) * 1997-11-14 2005-03-08 Medtronic Vascular, Inc. Deformable scaffolding multicellular stent
US6881199B2 (en) * 1998-09-10 2005-04-19 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6926690B2 (en) * 1998-09-10 2005-08-09 Percardia, Inc. Transmyocardial shunt and its attachment mechanism, for left ventricular revascularization
US6929009B2 (en) * 1996-08-26 2005-08-16 Medtronic Vascular, Inc. Method and apparatus for transmyocardial direct coronary revascularization
US7025773B2 (en) * 1999-01-15 2006-04-11 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US7083588B1 (en) * 1998-05-26 2006-08-01 Medtronic Vascular, Inc. Apparatus for providing coronary retroperfusion and methods of use
US20070055344A1 (en) * 1998-02-13 2007-03-08 Gittings Darin C Devices and methods for use in performing transmyocardial coronary bypass
US7191015B2 (en) * 2002-04-11 2007-03-13 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US20070106147A1 (en) * 2005-11-01 2007-05-10 Altmann Andres C Controlling direction of ultrasound imaging catheter
US20070185567A1 (en) * 2006-01-25 2007-08-09 Heuser Richard R Catheter system with stent device for connecting adjacent blood vessels
US20070203572A1 (en) * 2006-01-25 2007-08-30 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
US20080009936A1 (en) * 2006-05-05 2008-01-10 Eidosmed, Llc Stent device for anastomoses of blood vessels and other tubular organs
US7351247B2 (en) * 2002-09-04 2008-04-01 Bioconnect Systems, Inc. Devices and methods for interconnecting body conduits
US7357794B2 (en) * 2002-01-17 2008-04-15 Medtronic Vascular, Inc. Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US7374567B2 (en) * 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US7648517B2 (en) * 1995-10-13 2010-01-19 Medtronic Vascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US20100016709A1 (en) * 1998-09-24 2010-01-21 Pinhas Gilboa System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure
US7655033B2 (en) * 2004-12-09 2010-02-02 Med Institute, Inc. S-shaped stent design
US20100069820A1 (en) * 2006-09-01 2010-03-18 Zotz Rainer J Device, system, kit, and method for epicardial access
US20100087732A1 (en) * 2008-10-02 2010-04-08 Vascular Imaging Corporation Optical ultrasound receiver
US20100094391A1 (en) * 2008-10-10 2010-04-15 Kevin Heraty Stent suitable for deployment in a blood vessel
US20100113919A1 (en) * 2008-11-03 2010-05-06 Michael Maschke Catheter arangement for insertion into a blood vessel for minimally invasive intervention
US7722658B2 (en) * 2000-03-01 2010-05-25 Medinol Ltd. Longitudinally flexible stent
US7722663B1 (en) * 2000-04-24 2010-05-25 Scimed Life Systems, Inc. Anatomically correct endoluminal prostheses
US7749239B2 (en) * 2003-04-28 2010-07-06 De Winter Erwin Screw-device for anastomosis
US20100174357A1 (en) * 2009-01-07 2010-07-08 Lemaitre Vascular, Inc. Vascular Prosthesis of Varying Flexibility
US20110009740A1 (en) * 1998-06-30 2011-01-13 Hauck John A System and method for navigating an ultrasound catheter to image a beating heart
US7892246B2 (en) * 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US7892247B2 (en) * 2001-10-03 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting vessels
US20110054589A1 (en) * 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same
US7955343B2 (en) * 1996-02-02 2011-06-07 Medtronic Vascular, Inc. Methods and apparatus for blocking flow through blood vessel
US7966057B2 (en) * 2001-02-06 2011-06-21 Medtronic Vascular, Inc. Methods and apparatus for guided transluminal interventions using vessel wall penetrating catheters and other apparatus
US20110152994A1 (en) * 2009-12-22 2011-06-23 William Cook Europe Aps Implantable device
US20110160751A1 (en) * 2006-06-06 2011-06-30 Luiz Gonzaga Granja Filho Extraluminal stent type prosthesis for anastomosis
US8109947B2 (en) * 1998-11-06 2012-02-07 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US20120065652A1 (en) * 2010-09-10 2012-03-15 Cully Edward H Anastomotic devices and methods

Family Cites Families (329)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3848579A (en) 1973-02-23 1974-11-19 Real A Villa Automatic elasto-valvular hypodermic sampling needle
US4560374A (en) 1983-10-17 1985-12-24 Hammerslag Julius G Method for repairing stenotic vessels
US4586919A (en) 1984-04-06 1986-05-06 Taheri Syde A External shunt and method for procuring and preserving the endothelium of a vein used in arterial bypass
US4655746A (en) 1985-12-02 1987-04-07 Target Therapeutics Catheter device
US4768508A (en) 1986-06-06 1988-09-06 Thomas J. Fogarty Vein valve cutting method
US4739760A (en) 1986-06-06 1988-04-26 Thomas J. Fogarty Vein valve cutter apparatus
US4757821A (en) * 1986-11-12 1988-07-19 Corazonix Corporation Omnidirectional ultrasonic probe
US5273042A (en) 1987-10-28 1993-12-28 Medical Parameters, Inc. Guidewire advancement method
US4952215A (en) 1988-02-29 1990-08-28 Boisurge, Inc. Valvulotome with leaflet disruption heads and fluid supply
US5234450A (en) 1989-07-28 1993-08-10 Jacob Segalowitz Valvulotome catheter
US5092872A (en) 1989-07-28 1992-03-03 Jacob Segalowitz Valvulotome catheter
US5047041A (en) 1989-08-22 1991-09-10 Samuels Peter B Surgical apparatus for the excision of vein valves in situ
EP0467516A1 (en) 1990-07-20 1992-01-22 Cabot Technology Corporation Hemostatic stent
US5720776A (en) 1991-10-25 1998-02-24 Cook Incorporated Barb and expandable transluminal graft prosthesis for repair of aneurysm
US5284478A (en) 1992-06-08 1994-02-08 Nobles Anthony A Detachable tip optical valvulotome
US5203777A (en) 1992-03-19 1993-04-20 Lee Peter Y Radiopaque marker system for a tubular device
US5304189A (en) 1992-04-09 1994-04-19 Lafeber Company Venous valve cutter for in situ incision of venous valve leaflets
JP3860227B2 (en) * 1993-03-10 2006-12-20 株式会社東芝 Ultrasonic therapy device used under MRI guide
US5590654A (en) 1993-06-07 1997-01-07 Prince; Martin R. Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
US5782904A (en) 1993-09-30 1998-07-21 Endogad Research Pty Limited Intraluminal graft
US6685736B1 (en) 1993-09-30 2004-02-03 Endogad Research Pty Limited Intraluminal graft
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6190379B1 (en) 1995-06-06 2001-02-20 Sun Star Technology, Inc. Hot tip catheter
AU6396496A (en) 1995-07-07 1997-02-10 W.L. Gore & Associates, Inc. Interior liner for tubes, pipes and blood conduits
US6193745B1 (en) 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US6283983B1 (en) 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
CN1204244A (en) 1995-10-13 1999-01-06 血管转换公司 Device. system and method for interstitial transvascular
US6287336B1 (en) 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5747128A (en) 1996-01-29 1998-05-05 W. L. Gore & Associates, Inc. Radially supported polytetrafluoroethylene vascular graft
IL125416A0 (en) 1996-02-02 1999-03-12 Transvascular Inc Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
WO1999002105A1 (en) 1997-07-08 1999-01-21 Novo Rps Ulc Expandable stent
US5676670A (en) 1996-06-14 1997-10-14 Beth Israel Deaconess Medical Center Catheter apparatus and method for creating a vascular bypass in-vivo
US6447539B1 (en) 1996-09-16 2002-09-10 Transvascular, Inc. Method and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US6840936B2 (en) 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
DE69732791T2 (en) 1996-11-07 2005-09-15 St. Jude Medical ATG, Inc., Maple Grove Medical graft connector
JP2002513301A (en) 1996-11-07 2002-05-08 メドトロニック インステント,インコーポレーテッド Stent with variable flexibility
US5759174A (en) 1997-01-29 1998-06-02 Cathco, Inc. Angioplasty balloon with an expandable external radiopaque marker band
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6102884A (en) 1997-02-07 2000-08-15 Squitieri; Rafael Squitieri hemodialysis and vascular access systems
DE19720115C2 (en) 1997-05-14 1999-05-20 Jomed Implantate Gmbh Stent graft
EP0890346A1 (en) 1997-06-13 1999-01-13 Gary J. Becker Expandable intraluminal endoprosthesis
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US6532964B2 (en) 1997-07-11 2003-03-18 A-Med Systems, Inc. Pulmonary and circulatory blood flow support devices and methods for heart surgery procedures
US6889082B2 (en) 1997-10-09 2005-05-03 Orqis Medical Corporation Implantable heart assist system and method of applying same
GB2331365B (en) 1997-11-15 2002-03-13 Roke Manor Research Catheter tracking system
US6475170B1 (en) 1997-12-30 2002-11-05 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
JP3806601B2 (en) 1998-01-14 2006-08-09 住友ベークライト株式会社 Puncture balloon catheter and medical tube introduction tool using the catheter
US6081738A (en) 1998-01-15 2000-06-27 Lumend, Inc. Method and apparatus for the guided bypass of coronary occlusions
JP2002501780A (en) 1998-01-30 2002-01-22 ウィルク パテント デベロップメント コーポレイション Transmyocardial coronary artery bypass and revascularization
US6099559A (en) 1998-05-28 2000-08-08 Medtronic Ave, Inc. Endoluminal support assembly with capped ends
US6164281A (en) 1998-07-20 2000-12-26 Zhao; Iris Ginron Method of making and/or treating diseases characterized by neovascularization
US6156064A (en) 1998-08-14 2000-12-05 Schneider (Usa) Inc Stent-graft-membrane and method of making the same
ATE322230T1 (en) 1998-09-10 2006-04-15 Percardia Inc TMR DEVICE
US6368345B1 (en) 1998-09-30 2002-04-09 Edwards Lifesciences Corporation Methods and apparatus for intraluminal placement of a bifurcated intraluminal garafat
AUPP633898A0 (en) 1998-10-02 1998-10-29 Baxter International Inc. Guidewire capture device
US6475222B1 (en) 1998-11-06 2002-11-05 St. Jude Medical Atg, Inc. Minimally invasive revascularization apparatus and methods
US6336937B1 (en) 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6193763B1 (en) 1998-12-17 2001-02-27 Robert A. Mackin Apparatus and method for contemporaneous treatment and fluoroscopic mapping of body tissue
US7578828B2 (en) 1999-01-15 2009-08-25 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6254610B1 (en) 1999-05-24 2001-07-03 Impulse Dynamics N.V. Device and method for dragging and positioning a member within a duct in a body
US6824549B1 (en) 2000-06-07 2004-11-30 Iris Ginron Chao Method & device for making reversed bypass with cultured vessel in situ
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6258117B1 (en) 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6730116B1 (en) 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6126649A (en) 1999-06-10 2000-10-03 Transvascular, Inc. Steerable catheter with external guidewire as catheter tip deflector
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6364900B1 (en) 1999-07-14 2002-04-02 Richard R. Heuser Embolism prevention device
US6569193B1 (en) 1999-07-22 2003-05-27 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
US6251116B1 (en) 1999-07-28 2001-06-26 Vasconnect, Inc. Device for interconnecting vessels in a patient
US6458140B2 (en) 1999-07-28 2002-10-01 Vasconnect, Inc. Devices and methods for interconnecting vessels
US7300444B1 (en) 1999-07-28 2007-11-27 Cardica, Inc. Surgical system and method for connecting hollow tissue structures
US6165185A (en) 1999-07-28 2000-12-26 Vasconnect, Inc. Method for interconnecting vessels in a patient
US6159197A (en) 1999-09-17 2000-12-12 Richard R. Heuser Method and apparatus for treating body tissues and bodily fluid vessels
US20090093791A1 (en) 1999-09-17 2009-04-09 Heuser Richard R Devices and methods for treating chronic total occlusion
US20070265563A1 (en) 2006-05-11 2007-11-15 Heuser Richard R Device for treating chronic total occlusion
US6527741B1 (en) 1999-12-21 2003-03-04 Advanced Cardiovascular Systems, Inc. Angioplasty catheter system with adjustable balloon length
JP4166016B2 (en) * 2000-01-04 2008-10-15 メドトロニック ヴァスキュラー インコーポレイテッド A device that forms a pathway between adjacent body lumens
WO2001056500A2 (en) 2000-02-03 2001-08-09 Cook Incorporated Implantable vascular device
SG86458A1 (en) 2000-03-01 2002-02-19 Medinol Ltd Longitudinally flexible stent
US6536949B1 (en) 2000-03-07 2003-03-25 Richard R. Heuser Catheter for thermal evaluation of arteriosclerotic plaque
US20020048310A1 (en) 2000-03-07 2002-04-25 Heuser Richard R. Catheter for thermal and ultrasound evaluation of arteriosclerotic plaque
AU2001243554A1 (en) 2000-03-10 2001-09-24 Radius Medical Technologies, Inc. Surgical snare apparatus
SE523427C2 (en) 2000-03-20 2004-04-20 Jan Otto Solem Catheter system for bypassing an artery block
AU5062601A (en) 2000-04-18 2001-10-30 Impulse Dynamics N.V. Method and device for inserting leads into coronary veins
US6854467B2 (en) 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6652576B1 (en) 2000-06-07 2003-11-25 Advanced Cardiovascular Systems, Inc. Variable stiffness stent
US7632303B1 (en) 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US6464665B1 (en) 2000-07-05 2002-10-15 Richard R. Heuser Catheter apparatus and method for arterializing a vein
US20050113798A1 (en) 2000-07-21 2005-05-26 Slater Charles R. Methods and apparatus for treating the interior of a blood vessel
US6585762B1 (en) 2000-08-10 2003-07-01 Paul Stanish Arteriovenous grafts and methods of implanting the same
JP2004534552A (en) 2000-08-10 2004-11-18 ダイアリシス・アクセス・ソルーションズ・インコーポレーテッド Distally narrowed vascular graft and method of using the same to make arterial-to-venous and arterial-to-arterial connections
EP1341482B2 (en) 2000-12-11 2016-05-18 OrbusNeich Medical, Inc. Stent having helical elements
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
IL144213A0 (en) 2001-07-09 2002-05-23 Mind Guard Ltd Implantable filter
US20040073282A1 (en) 2001-08-06 2004-04-15 Paul Stanish Distally-narrowed vascular grafts and methods of using same for making artery-to-vein and artery-to-artery connections
US20030139802A1 (en) 2001-12-06 2003-07-24 Wulfman Edward I. Medical device
US20030109827A1 (en) 2001-12-07 2003-06-12 Elan Pharma International Limited Drug delivery system and method
US7163553B2 (en) 2001-12-28 2007-01-16 Advanced Cardiovascular Systems, Inc. Intravascular stent and method of use
US6858038B2 (en) 2002-06-21 2005-02-22 Richard R. Heuser Stent system
AU2003258976B2 (en) 2002-06-28 2008-05-29 Cook Incorporated Thoracic aortic aneurysm stent graft.
US7137963B2 (en) 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US7300459B2 (en) 2002-10-17 2007-11-27 Heuser Richard R Stent with covering and differential dilation
US7144422B1 (en) 2002-11-13 2006-12-05 Advanced Cardiovascular Systems, Inc. Drug-eluting stent and methods of making the same
US20050165469A1 (en) 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US7166088B2 (en) 2003-01-27 2007-01-23 Heuser Richard R Catheter introducer system
US8066674B2 (en) 2003-01-27 2011-11-29 Heuser Richard R Catheter introducer system
US7967769B2 (en) 2003-04-08 2011-06-28 Rox Medical Inc. Implantable arterio-venous shunt devices and methods for their use
US20040249335A1 (en) 2003-04-08 2004-12-09 Faul John L. Implantable arteriovenous shunt device
ITBO20030239A1 (en) 2003-04-18 2004-10-19 Bruno Pasquale Franco Nardo DEVICE FOR THE ARTERIALIZATION OF THE DOOR VEIN AND RELATED KIT FOR ITS APPLICATION ON THE BODY OF A PATIENT.
US20040215220A1 (en) 2003-04-24 2004-10-28 Dolan Mark J. Anastomotic stent, apparatus and methods of use thereof
ATE474611T1 (en) 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
US20040230289A1 (en) 2003-05-15 2004-11-18 Scimed Life Systems, Inc. Sealable attachment of endovascular stent to graft
IES20030539A2 (en) 2003-07-22 2005-05-18 Medtronic Vascular Connaught Stents and stent delivery system
US7402141B2 (en) 2003-08-27 2008-07-22 Heuser Richard R Catheter guidewire system using concentric wires
DE10351220A1 (en) 2003-10-28 2005-06-02 Deutsche Institute für Textil- und Faserforschung Stuttgart - Stiftung des öffentlichen Rechts Tubular implant
WO2005051206A1 (en) 2003-11-21 2005-06-09 Vnus Medical Technologies, Inc. Method and apparatus for treating a carotid artery
US7763011B2 (en) 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
US7717930B2 (en) 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US20050209617A1 (en) 2004-03-05 2005-09-22 Paul Koven Valvulotome
US20080228209A1 (en) 2004-03-08 2008-09-18 Demello Richard M System and method for removal of material from a blood vessel using a small diameter catheter
US20050203551A1 (en) 2004-03-09 2005-09-15 Kevin Weadock Method for performing a coronary artery bypass graft procedure
US20050203549A1 (en) 2004-03-09 2005-09-15 Fidel Realyvasquez Methods and apparatus for off pump aortic valve replacement with a valve prosthesis
US8747344B2 (en) 2004-03-29 2014-06-10 Nazir A. Khan Hybrid arteriovenous shunt
US8282591B2 (en) 2004-03-29 2012-10-09 Iftikhar Khan Hybrid arteriovenous shunt
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
CN2728440Y (en) 2004-07-30 2005-09-28 北京有色金属研究总院 Aorta tectorial membrane stent
CN100352406C (en) 2004-08-17 2007-12-05 微创医疗器械(上海)有限公司 Combined membrane-covered stent capable of being bent in any direction
US20080154153A1 (en) 2004-08-25 2008-06-26 Heuser Richard R Multiple-wire systems and methods for ablation of occlusions within blood vessels
US20090012429A1 (en) 2004-08-25 2009-01-08 Heuser Richard R Catheter guidewire system using concentric wires
US8545418B2 (en) 2004-08-25 2013-10-01 Richard R. Heuser Systems and methods for ablation of occlusions within blood vessels
GB0419954D0 (en) 2004-09-08 2004-10-13 Advotek Medical Devices Ltd System for directing therapy
EP2468348B1 (en) 2004-09-17 2016-10-26 Codman & Shurtleff, Inc. Thin film metallic devices for plugging aneurysms or vessels
US7618374B2 (en) 2004-09-27 2009-11-17 Siemens Medical Solutions Usa, Inc. Image plane sensing methods and systems for intra-patient probes
US20060116713A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
CA2588726A1 (en) 2004-11-26 2006-06-01 The Regents Of The University Of California Devices, systems and methods for controlling local blood pressure
US7632242B2 (en) 2004-12-09 2009-12-15 Boston Scientific Scimed, Inc. Catheter including a compliant balloon
US8226592B2 (en) 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7828837B2 (en) 2005-02-17 2010-11-09 Khoury Medical Devices, LLC. Vascular endograft
US8372097B2 (en) 2005-03-04 2013-02-12 Koven Technology Canada Inc. Valvulotome
US8961586B2 (en) 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
EP1898811B1 (en) 2005-06-30 2019-03-06 Rox Medical, Inc. Devices and systems for creation of a peripherally located fistula
CN2843384Y (en) 2005-07-12 2006-12-06 北京有色金属研究总院 A kind of aortic blood pipe holder
US8231646B2 (en) 2005-07-29 2012-07-31 Cvdevices, Llc Device and methods for controlling blood perfusion pressure using a retrograde cannula
US20070179590A1 (en) 2005-12-29 2007-08-02 Wenfeng Lu Hybrid intraluminal device with varying expansion force
US9375215B2 (en) 2006-01-20 2016-06-28 W. L. Gore & Associates, Inc. Device for rapid repair of body conduits
US8062321B2 (en) 2006-01-25 2011-11-22 Pq Bypass, Inc. Catheter system for connecting adjacent blood vessels
US20080161904A1 (en) 2006-01-25 2008-07-03 Heuser Richard R Connection of adjacent blood vessels
US20070203515A1 (en) 2006-01-25 2007-08-30 Heuser Richard R Catheter system for connecting adjacent blood vessels
US20080161901A1 (en) 2006-01-25 2008-07-03 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
US8235916B2 (en) 2006-02-03 2012-08-07 Pacesetter, Inc. System and method for manipulating insertion pathways for accessing target sites
GB0607761D0 (en) 2006-04-20 2006-05-31 Site Specific Therapies Ltd Variable density stent
US20130190676A1 (en) 2006-04-20 2013-07-25 Limflow Gmbh Devices and methods for fluid flow through body passages
US8197499B2 (en) 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
EP2034906A4 (en) 2006-06-21 2010-07-28 Univ Leland Stanford Junior Compositions and methods for joining non-conjoined lumens
DE102006036073A1 (en) 2006-08-02 2008-02-07 Heise, Michael, Dr.med. Vascular tubular graft
GB0617074D0 (en) 2006-08-30 2006-10-11 Angiomed Ag Arteriovenous fistula
US9539124B1 (en) 2006-11-21 2017-01-10 Seshadri Raju Venous stent
US8636791B1 (en) 2006-11-21 2014-01-28 Seshadri Raju Venous stent
EP2088962B1 (en) 2006-11-22 2017-10-11 Inspiremd Ltd. Optimized stent jacket
US20130150943A1 (en) 2007-01-19 2013-06-13 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20080177249A1 (en) 2007-01-22 2008-07-24 Heuser Richard R Catheter introducer system
WO2008091570A2 (en) 2007-01-23 2008-07-31 Dtherapeutics, Llc Devices, systems and methods for controlling local blood pressure
US20080234813A1 (en) 2007-03-20 2008-09-25 Heuser Richard R Percutaneous Interventional Cardiology System for Treating Valvular Disease
WO2008150905A1 (en) 2007-05-29 2008-12-11 Kassab Ghassan S Devices, systems, and methods for achieving gastric bypass
US8852112B2 (en) 2007-06-28 2014-10-07 W. L. Gore & Associates, Inc. Catheter with deflectable imaging device and bendable electrical conductor
WO2009012473A2 (en) 2007-07-18 2009-01-22 Silk Road Medical, Inc. Methods and systems for establishing retrograde carotid arterial blood flow
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
US9282967B2 (en) 2007-08-02 2016-03-15 Bioconnect Systems, Inc. Implantable flow connector
US8652084B2 (en) 2007-08-09 2014-02-18 Indiana University Research And Technology Corporation Arteriovenous shunt with integrated surveillance system
CA2710002A1 (en) 2007-12-20 2009-07-09 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
EP2231214A2 (en) 2007-12-21 2010-09-29 Boston Scientific Scimed, Inc. Flexible stent-graft device having patterned polymeric coverings
US20090192485A1 (en) 2008-01-28 2009-07-30 Heuser Richard R Snare device
FR2928078B1 (en) 2008-02-28 2010-03-26 Vascular Office PROTHETIC DEVICE FOR REALIZING VASCULAR BRIDGING WITHOUT CLASSIFICATION FROM A BLOOD VESSEL
CA2717794A1 (en) 2008-02-28 2009-09-03 Fistulink Ltd. Apparatus and method for creating arteriovenous fistulas
CA2726495C (en) 2008-06-10 2013-12-10 Bavaria Medizin Technologie Gmbh Scoring catheter for treating diseased heart valves
US20090312617A1 (en) 2008-06-12 2009-12-17 Jerett Creed Needle injection catheter
US20110264104A1 (en) 2009-08-03 2011-10-27 The Methodist Hospital Research Institute Hemodialysis grafts and methods for localizing and identifying the placement of same
US8771305B2 (en) 2008-11-11 2014-07-08 Edgar Louis Shriver Lateral intravascular excision/incision devices
US20100131000A1 (en) 2008-11-21 2010-05-27 Radius Medical Technologies, Inc. System and method for removal of material from a blood vessel
US8888733B2 (en) 2008-12-19 2014-11-18 Cvdevices, Llc Devices, systems, and methods for autoretroperfusion
US9504781B2 (en) 2008-12-19 2016-11-29 Cvdevices, Llc Peripheral arterialization devices and methods of using the same
JP5513520B2 (en) 2008-12-19 2014-06-04 シーヴィ デヴァイシズ,エルエルシー Automatic retrograde perfusion device, system and method for achieving arterialization of venous blood
US9968727B2 (en) 2008-12-19 2018-05-15 Cvdevices, Llc Systems, devices, and methods for organ retroperfusion along with regional mild hypothermia
US8968230B2 (en) 2011-08-30 2015-03-03 Cvdevices, Llc Coil occlusion devices and systems and methods of using the same
US8945039B2 (en) 2008-12-19 2015-02-03 Cvdevices, Llc Devices, systems, and methods for organ retroperfusion
US20100185172A1 (en) 2009-01-20 2010-07-22 Mariel Fabro Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods
WO2010107950A1 (en) 2009-03-17 2010-09-23 Cytograft Tissue Engineering, Inc. Guided percutaneous bypass
WO2010123668A1 (en) 2009-04-20 2010-10-28 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8784467B2 (en) 2009-05-15 2014-07-22 Lemaitre Vascular, Inc. Non-occlusive dilation devices
US20110251482A1 (en) 2009-10-29 2011-10-13 Rox Medical, Inc. Devices, systems and methods for enhanced visualization of the anatomy of a patient
WO2011056981A2 (en) 2009-11-04 2011-05-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
WO2011060249A2 (en) 2009-11-13 2011-05-19 The Brigham And Women's Hospital, Inc. Methods and apparatus for vascular anastomosis
US8251943B1 (en) 2010-01-06 2012-08-28 The United States Of America As Represented By The Secretary Of The Air Force Vascular shunt
EP2528537A4 (en) 2010-01-27 2016-09-07 Vascular Therapies Inc Device and method for preventing stenosis at an anastomosis site
DE102010009723A1 (en) 2010-03-01 2011-09-01 Andramed Gmbh Guidewire / catheter guided valvulotome
US20120046733A1 (en) 2010-04-14 2012-02-23 Randolf Von Oepen Method of delivering a medical device across a valve
WO2011137215A1 (en) 2010-04-29 2011-11-03 Vanderbilt University Percutaneous collateral bypass
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9452015B2 (en) 2010-06-15 2016-09-27 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
CA2804524C (en) 2010-06-15 2018-04-10 Caymus Medical, Inc. Systems and methods for creating arteriovenous (av) fistulas
EP2473121B1 (en) 2010-06-22 2014-09-17 LeMaitre Vascular, Inc. Over-the-wire valvulotomes
US20110319902A1 (en) 2010-06-26 2011-12-29 Scott Epstein Catheter delivery system
JP4815024B1 (en) 2010-07-02 2011-11-16 日機装株式会社 Artificial blood vessels and artificial blood vessel access ports
JP4991014B2 (en) 2010-07-07 2012-08-01 日機装株式会社 Artificial blood vessel
US20120035706A1 (en) 2010-08-03 2012-02-09 Cook Medical Technologies Llc Blood perfusion device delivery system
US9623228B2 (en) 2010-08-12 2017-04-18 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
CA2748206C (en) 2010-08-21 2015-06-23 Blayne A. Roeder Prosthesis having pivoting fenestration
US20120095500A1 (en) 2010-10-14 2012-04-19 Heuser Richard R Concentric wire embolism protection device
US20120116354A1 (en) 2010-11-08 2012-05-10 Heuser Richard R Devices and methods for small vessel access
US9271733B2 (en) 2010-11-11 2016-03-01 Willson T. Asfora Sutureless vascular anastomosis connection
US9345484B2 (en) 2010-11-11 2016-05-24 Asfora Ip, Llc Deployment tool for sutureless vascular anastomosis connection
WO2012063242A1 (en) 2010-11-12 2012-05-18 Erodium Medical Ltd. Percutaneous heart bypass graft surgery apparatus
US9017323B2 (en) 2010-11-16 2015-04-28 Tva Medical, Inc. Devices and methods for forming a fistula
WO2012087301A1 (en) 2010-12-21 2012-06-28 Microvention, Inc. Stent
US20120179238A1 (en) 2011-01-10 2012-07-12 Peritec Biosciences, Ltd. Stent having variable stiffness
US20120203329A1 (en) 2011-02-07 2012-08-09 Heuser Richard R Bifurcated stent and method of use
EP3275402B1 (en) 2011-03-17 2021-08-25 PQ Bypass, Inc. Differential dilation stent
US20120271400A1 (en) 2011-04-21 2012-10-25 Lyons Drew P Introducer for a vascular repair prosthesis
US8784474B2 (en) 2011-04-21 2014-07-22 Cook Medical Technologies Llc Emergency vascular repair system and method
US9138230B1 (en) 2011-04-29 2015-09-22 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US20120290072A1 (en) 2011-05-12 2012-11-15 Theobald Elizabeth A Emergency vascular repair prosthesis
US10335296B2 (en) 2011-05-17 2019-07-02 The University Of Kentucky Research Foundation Graft within a graft endoluminal graft
US20120310209A1 (en) 2011-06-02 2012-12-06 Cook Medical Technologies LLC. Catheter And Treatment Methods For Lower Leg Ischemia
WO2012174389A1 (en) 2011-06-15 2012-12-20 Phraxis Inc. Anastomotic connector and system for delivery
WO2012174361A1 (en) 2011-06-15 2012-12-20 Phraxis Inc. Arterial venous spool anchor
US8815278B2 (en) 2011-07-19 2014-08-26 Abbott Cardiovascular Systems Inc. Drug delivery device and method
US11026708B2 (en) 2011-07-26 2021-06-08 Thrombx Medical, Inc. Intravascular thromboembolectomy device and method using the same
EP2739327B1 (en) 2011-08-01 2019-07-24 Laminate Medical Technologies Ltd Vessel shaping devices
US8951222B2 (en) 2011-08-10 2015-02-10 Western Vascular Institute Arterial shunt
EP2741804B1 (en) 2011-08-11 2017-04-26 Osprey Medical Inc. Systems and methods for limb treatment
US20130053732A1 (en) 2011-08-24 2013-02-28 Richard R. Heuser Devices and methods for treating hypertension with energy
US8574283B1 (en) 2011-08-30 2013-11-05 Suraj Govind Kamat Deployment of stents within bifurcated vessels
CN103874794B (en) 2011-09-01 2016-04-13 库克医学技术有限责任公司 Screw line support of braiding and forming method thereof
SG11201401358VA (en) 2011-10-10 2014-05-29 Univ Singapore Membrane for covering a peripheral surface of a stent
WO2013067446A1 (en) 2011-11-04 2013-05-10 Caymus Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US9364255B2 (en) 2011-11-09 2016-06-14 Boston Scientific Scimed, Inc. Medical cutting devices and methods of use
US9504552B2 (en) 2011-11-30 2016-11-29 Cook Medical Technologies Llc Hemodialysis graft
CN103945793B (en) 2011-12-06 2016-05-04 俄奥梯科创新有限公司 For device and the using method thereof of repairing in aorta lumen
JP2015506230A (en) 2012-01-12 2015-03-02 コルファスコ メディカル ベスローテン フェンノートシャップCorvasco Medical B.V. Blood vessel junction
US10548706B2 (en) 2012-01-13 2020-02-04 Volcano Corporation Retrieval snare device and method
DE102012100754A1 (en) 2012-01-31 2013-08-01 Jotec Gmbh Modular stent graft
US8968233B2 (en) 2012-02-03 2015-03-03 Medtronic Vascular, Inc. Arteriovenous shunt having a moveable valve
JP6182545B2 (en) 2012-02-08 2017-08-16 アベヌ メディカル インコーポレイテッドAvenu Medical,Inc. Intravascular arteriovenous anastomosis and tissue junction catheter
US9056171B2 (en) 2012-02-24 2015-06-16 Medtronic Vascular, Inc. Arteriovenous shunt having eccentric anchor stent
US9067050B2 (en) 2012-03-30 2015-06-30 Medtronic Vascular, Inc. Arteriovenous shunt having a flow control mechanism
US10434293B2 (en) 2012-04-15 2019-10-08 Tva Medical, Inc. Implantable flow connector
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector
WO2013163227A1 (en) 2012-04-23 2013-10-31 Pq Bypass, Inc. Methods and systems for bypassing occlusions in a femoral artery
EP2849834B1 (en) 2012-05-17 2020-07-29 Lake Region Manufacturing, Inc. d/b/a Lake Region Medical Capture device
US9623217B2 (en) 2012-05-30 2017-04-18 Vascular Access Techonlogies, Inc. Transvascular access methods
US20140052170A1 (en) 2012-08-17 2014-02-20 Richard R. Heuser Embolism protection device
CA2922640A1 (en) 2012-08-30 2014-03-06 Celso Bagaoisan Devices and methods for the treatment of vascular disease
US9486276B2 (en) 2012-10-11 2016-11-08 Tva Medical, Inc. Devices and methods for fistula formation
JP6175511B2 (en) 2012-11-14 2017-08-02 アベヌ メディカル インコーポレイテッドAvenu Medical,Inc. A device to create an arteriovenous fistula
US9180033B2 (en) 2012-11-20 2015-11-10 Indiana University Research And Technology Corp. Intravascular shunt for traumatized arteries
AU2012258395B1 (en) 2012-11-27 2013-03-28 Cook Medical Technologies Llc Assembly of stent grafts with diameter reducing ties
US10039657B2 (en) 2012-12-21 2018-08-07 CARDINAL HEALTH SWITZERLAND 515 GmbH Cannulation guiding device for bifurcated stent and method of use
US10835367B2 (en) 2013-03-08 2020-11-17 Limflow Gmbh Devices for fluid flow through body passages
CN105101912B (en) 2013-03-08 2017-08-29 林弗洛公司 There is provided or maintain the method and system of the fluid stream by body passage
US20140270067A1 (en) 2013-03-14 2014-09-18 Stephen Knecht Clark Radiographic marker
US10821217B2 (en) 2013-03-14 2020-11-03 Tva Medical, Inc. Fistula formation devices and methods therefor
US11400196B2 (en) 2013-03-15 2022-08-02 Tomislav Deur Controlled arterial/venous access
WO2014145021A1 (en) 2013-03-15 2014-09-18 Orange County Glaucoma, Pc Enhancement of aqueous flow
FR3003747B1 (en) 2013-04-02 2015-05-08 Xavier Renard SYSTEM FOR ACHIEVING TWO BLOOD VESSELS.
WO2014176458A2 (en) 2013-04-24 2014-10-30 Trustees Of Tufts College Bioresorbable biopolymer anastomosis devices
US20150011925A1 (en) 2013-07-08 2015-01-08 Robert F. Buckman, Jr. Method and device for temporary emergency vessel anastomoses
EP3027243B1 (en) 2013-07-31 2019-03-27 CVDevices, LLC Unitary body systems and devices and methods to use the same for retroperfusion
US10070866B1 (en) 2013-08-01 2018-09-11 Avenu Medical, Inc. Percutaneous arterial to venous anastomosis clip application catheter system and methods
CN104586536B (en) 2013-10-31 2017-05-03 微创心脉医疗科技(上海)有限公司 Covered stent
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
JP2017509366A (en) 2014-01-14 2017-04-06 ボルケーノ コーポレイション Catheter assembly for vascular access site creation
JP6841659B2 (en) 2014-01-14 2021-03-10 ボルケーノ コーポレイション Devices and methods for forming vascular access
SG11201606240UA (en) 2014-01-30 2016-08-30 Singapore Health Serv Pte Ltd Arterial sheath which allows distal perfusion within a cannulated vessel
WO2015119705A1 (en) 2014-02-04 2015-08-13 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Endovascular apparatus for perfusing organs in a body
DE102015101418B4 (en) 2014-02-04 2018-05-30 Takatoshi FURUYA Venous valve cutting device and method for its production
WO2015138998A1 (en) 2014-03-14 2015-09-17 Tva Medical, Inc. Fistula formation devices and methods therefor
GB2527075A (en) 2014-03-17 2015-12-16 Daassist As Percutaneous system, devices and methods
WO2015183489A1 (en) 2014-05-30 2015-12-03 Endologix, Inc. Modular stent graft systems and methods with inflatable fill structures
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
WO2016033374A1 (en) 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
US10729454B2 (en) 2014-09-10 2020-08-04 Teleflex Life Sciences Limited Guidewire capture
JP6960334B2 (en) 2014-12-04 2021-11-05 トリバスキュラー インコーポレイテッド Internal iliac artery preservation device and method
US20160175569A1 (en) 2014-12-22 2016-06-23 Richard R. Heuser Device for treating vascular occlusion
EP3247290B1 (en) 2015-01-22 2020-06-17 Regents of the University of Minnesota Devices for minimally invasive transcatheter coronary artery bypass grafting
US10603040B1 (en) 2015-02-09 2020-03-31 Tva Medical, Inc. Methods for treating hypertension and reducing blood pressure with formation of fistula
AU2016228986B2 (en) 2015-03-10 2021-02-04 Stent Tek Limited Surgical system, device and methods of use thereof for the percutaneous creation of an arteriovenous fistula (AVF)
DE102015108518B3 (en) 2015-05-29 2016-10-06 CiS Forschungsinstitut für Mikrosensorik GmbH Method and device for determining the course of blood pressure
WO2017011402A1 (en) 2015-07-10 2017-01-19 Rox Medical, Inc. Methods, systems and devices for creating a blood flow pathway to treat a patient
US20180116522A1 (en) 2015-07-10 2018-05-03 Rox Medical, Inc. Methods, systems and devices for creating a blood flow pathway to treat a patient
US10898696B2 (en) 2015-07-13 2021-01-26 Cti Vascular Ag Hydraulically actuated and functionally integratable catheter system for treating vascular and non-vascular diseases and related methods
CN112057729A (en) 2015-07-13 2020-12-11 Cti血管公司 Mechanically driven and functionally integratable catheter system for treating vascular and non-vascular diseases
US10314591B2 (en) 2015-08-04 2019-06-11 Cook Medical Technologies Llc Medical device and corresponding method of use for arteriovenous fistula creation
US10492936B2 (en) 2015-10-30 2019-12-03 Ram Medical Innovations, Llc Apparatus and method for improved access of procedural catheter in tortuous vessels
JP6979021B2 (en) 2016-01-15 2021-12-08 ティーブイエー メディカル, インコーポレイテッド Devices and methods for advancing wires
CN108778171A (en) 2016-01-15 2018-11-09 Tva医疗公司 System and method for adhering to blood vessel
JP6894440B2 (en) 2016-01-15 2021-06-30 ティーブイエー メディカル, インコーポレイテッド Devices and methods for forming fistulas
US10874422B2 (en) 2016-01-15 2020-12-29 Tva Medical, Inc. Systems and methods for increasing blood flow
EP3407802B1 (en) 2016-01-29 2024-01-10 Bioventrix, Inc. Percutaneous arterial access to position transmyocardial implant devices
US20190269888A1 (en) 2016-07-28 2019-09-05 Tar Toong Victor Chao Arterial sheath which allows distal perfusion within a cannulated vessel
US11547583B2 (en) 2016-09-09 2023-01-10 Micro Medical Solutions, Inc. Method and apparatus for treating critical limb ischemia
JP6789386B2 (en) 2016-09-19 2020-11-25 シーティーアイ バスキュラー アーゲーCTI Vascular AG Catheter system for treating vascular and non-vascular diseases
US11285028B2 (en) 2016-09-25 2022-03-29 Tva Medical, Inc. Vascular stent devices and methods
WO2018067537A1 (en) 2016-10-07 2018-04-12 Pq Bypass Inc. Systems and methods for delivering stent grafts
US11654224B2 (en) 2016-12-30 2023-05-23 Vascular Access Technologies, Inc. Methods and devices for percutaneous implantation of arterio-venous grafts
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
CN108882975B (en) 2017-03-06 2022-03-15 拉姆医学创新股份有限公司 Device and method for improving access of surgical catheter in tortuous vessels
WO2018175850A1 (en) 2017-03-24 2018-09-27 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
CN110730634A (en) 2017-04-10 2020-01-24 林弗洛公司 Apparatus and method for treating the vasculature of a lower limb
EP3703627A4 (en) 2017-10-31 2021-08-11 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US10857014B2 (en) 2018-02-18 2020-12-08 Ram Medical Innovations, Llc Modified fixed flat wire bifurcated catheter and its application in lower extremity interventions
AU2019256795A1 (en) 2018-04-20 2020-11-12 Stent Tek Limited Apparatus for orientation display and alignment in percutaneous devices
US11491034B2 (en) 2018-06-08 2022-11-08 Efemoral Medical, Inc. Absorbable intravascular devices that shorten upon expansion creating space for vascular movement
WO2020072717A1 (en) 2018-10-05 2020-04-09 Board Of Regents Of The University Of Nebraska Bypass graft
AU2019359268A1 (en) 2018-10-09 2021-04-08 Limflow Gmbh Devices and methods for catheter alignment
WO2020081597A1 (en) 2018-10-15 2020-04-23 Aharon Alon S Magnetic puncture access and delivery systems and methods
US20200171282A1 (en) 2018-12-04 2020-06-04 Micro Medical Solutions, Inc. System and method for treatment of the claudification of the superficial femoral and proximal popliteal artery
US11382578B2 (en) 2018-12-12 2022-07-12 Nuxcel Limited Fluorscopic markers for single view positioning
EP3920997A1 (en) 2019-02-04 2021-12-15 Contract Medical International GmbH Systems and methods for diverting blood flow in blood vessels
US11471308B2 (en) 2019-05-20 2022-10-18 Wei Cheong Steven KUM Extravascular bypass systems and methods
JP7320625B2 (en) 2019-05-31 2023-08-03 ティーブイエー メディカル, インコーポレイテッド Systems, methods, and catheters for endovascular treatment of blood vessels
WO2021087294A1 (en) 2019-11-01 2021-05-06 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
CN115279282A (en) 2019-12-30 2022-11-01 Tva医疗公司 System for forming fistula
WO2021221607A1 (en) 2020-04-28 2021-11-04 Tva Medical, Inc. Systems, methods, and catheters for endovascular treatment of a blood vessel

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US625116A (en) * 1899-05-16 Edouard martin
US4249539A (en) * 1979-02-09 1981-02-10 Technicare Corporation Ultrasound needle tip localization system
US5397339A (en) * 1986-11-14 1995-03-14 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US5443497A (en) * 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US6746464B1 (en) * 1995-10-13 2004-06-08 Transvascular, Inc. Device, system and method for interstitial transvascular intervention
US7159592B1 (en) * 1995-10-13 2007-01-09 Medtronic Vascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US7729738B2 (en) * 1995-10-13 2010-06-01 Medtronic Vascular, Inc. Stabilized tissue penetrating catheters
US7059330B1 (en) * 1995-10-13 2006-06-13 Medtronic Vascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US7179270B2 (en) * 1995-10-13 2007-02-20 Medtronic Vascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US6068638A (en) * 1995-10-13 2000-05-30 Transvascular, Inc. Device, system and method for interstitial transvascular intervention
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US7648517B2 (en) * 1995-10-13 2010-01-19 Medtronic Vascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6375615B1 (en) * 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US7670329B2 (en) * 1995-10-13 2010-03-02 Medtronic Vascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6231587B1 (en) * 1995-10-13 2001-05-15 Transvascular, Inc. Devices for connecting anatomical conduits such as vascular structures
US6709444B1 (en) * 1996-02-02 2004-03-23 Transvascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US7955343B2 (en) * 1996-02-02 2011-06-07 Medtronic Vascular, Inc. Methods and apparatus for blocking flow through blood vessel
US6579311B1 (en) * 1996-02-02 2003-06-17 Transvascular, Inc. Method for interstitial transvascular intervention
US6858037B2 (en) * 1996-03-05 2005-02-22 Evysio Medical Devices Ulc Expandable stent and method for delivery of same
US7387636B2 (en) * 1996-03-15 2008-06-17 Medtronic Vascular, Inc. Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US6099542A (en) * 1996-03-15 2000-08-08 Beth Israel Hospital Association Inc. Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a prechosen anatomic site in-vivo
US6719781B1 (en) * 1996-06-14 2004-04-13 Aptus Medical Inc. Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US6929009B2 (en) * 1996-08-26 2005-08-16 Medtronic Vascular, Inc. Method and apparatus for transmyocardial direct coronary revascularization
US6186972B1 (en) * 1996-09-16 2001-02-13 James A. Nelson Methods and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US5655548A (en) * 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US6685648B2 (en) * 1996-10-11 2004-02-03 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US7094230B2 (en) * 1996-10-11 2006-08-22 Medtronic Vascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6379319B1 (en) * 1996-10-11 2002-04-30 Transvascular, Inc. Systems and methods for directing and snaring guidewires
US7316655B2 (en) * 1996-10-11 2008-01-08 Medtronic Vascular, Inc. Systems and methods for directing and snaring guidewires
US6432127B1 (en) * 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US6206912B1 (en) * 1996-11-07 2001-03-27 St. Jude Medical Anastomotic Technology Group Inc. Medical grafting methods and apparatus
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US7056325B1 (en) * 1997-06-28 2006-06-06 Medtronic Vascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6863684B2 (en) * 1997-11-14 2005-03-08 Medtronic Vascular, Inc. Deformable scaffolding multicellular stent
US6280388B1 (en) * 1997-11-19 2001-08-28 Boston Scientific Technology, Inc. Aerogel backed ultrasound transducer
US6221049B1 (en) * 1998-01-13 2001-04-24 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6511458B2 (en) * 1998-01-13 2003-01-28 Lumend, Inc. Vascular re-entry catheter
US6231546B1 (en) * 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
US6015405A (en) * 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US20070055344A1 (en) * 1998-02-13 2007-03-08 Gittings Darin C Devices and methods for use in performing transmyocardial coronary bypass
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6544230B1 (en) * 1998-03-31 2003-04-08 Transvascular, Inc. Catheters, systems and methods for percutaneous in situ arterio-venous bypass
US6561998B1 (en) * 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US7083588B1 (en) * 1998-05-26 2006-08-01 Medtronic Vascular, Inc. Apparatus for providing coronary retroperfusion and methods of use
US20110009740A1 (en) * 1998-06-30 2011-01-13 Hauck John A System and method for navigating an ultrasound catheter to image a beating heart
US6241744B1 (en) * 1998-08-14 2001-06-05 Fox Hollow Technologies, Inc. Apparatus for deploying a guidewire across a complex lesion
US20060116625A1 (en) * 1998-09-10 2006-06-01 Percardia, Inc. TMR shunt
US7736327B2 (en) * 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US6881199B2 (en) * 1998-09-10 2005-04-19 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6926690B2 (en) * 1998-09-10 2005-08-09 Percardia, Inc. Transmyocardial shunt and its attachment mechanism, for left ventricular revascularization
US7704222B2 (en) * 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20100016709A1 (en) * 1998-09-24 2010-01-21 Pinhas Gilboa System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure
US6711429B1 (en) * 1998-09-24 2004-03-23 Super Dimension Ltd. System and method for determining the location of a catheter during an intra-body medical procedure
US6217527B1 (en) * 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US8109947B2 (en) * 1998-11-06 2012-02-07 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US7025773B2 (en) * 1999-01-15 2006-04-11 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6517558B2 (en) * 1999-01-15 2003-02-11 Ventrica, Inc. Methods and devices for forming vascular anastomoses
US20040097990A1 (en) * 1999-01-27 2004-05-20 Zhao Iris Ginron Graft material, device & method of making
US6475226B1 (en) * 1999-02-03 2002-11-05 Scimed Life Systems, Inc. Percutaneous bypass apparatus and method
US6511491B2 (en) * 1999-03-09 2003-01-28 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6569145B1 (en) * 1999-03-25 2003-05-27 Transvascular, Inc. Pressure-controlled continuous coronary sinus occlusion device and methods of use
US7892246B2 (en) * 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US7722664B2 (en) * 1999-11-16 2010-05-25 Boston Scientific Scimed, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient
US7214241B2 (en) * 1999-11-16 2007-05-08 Boston Scientific Scimed, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US6610087B1 (en) * 1999-11-16 2003-08-26 Scimed Life Systems, Inc. Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance
US6685716B1 (en) * 2000-01-04 2004-02-03 Transvascular, Inc. Over-the-wire apparatus and method for open surgery making of fluid connection between two neighboring vessels
US6589164B1 (en) * 2000-02-15 2003-07-08 Transvascular, Inc. Sterility barriers for insertion of non-sterile apparatus into catheters or other medical devices
US6508824B1 (en) * 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US7722658B2 (en) * 2000-03-01 2010-05-25 Medinol Ltd. Longitudinally flexible stent
US7722663B1 (en) * 2000-04-24 2010-05-25 Scimed Life Systems, Inc. Anatomically correct endoluminal prostheses
US20020089262A1 (en) * 2000-05-09 2002-07-11 Minoru Topa Cylindrical transducer apparatus
US20020068869A1 (en) * 2000-06-27 2002-06-06 Axel Brisken Drug delivery catheter with internal ultrasound receiver
US6746426B1 (en) * 2000-07-11 2004-06-08 Medtronic Vascular, Inc. Transluminally deliverable vascular blockers and methods for facilitating retrograde flow of arterial blood through veins
US8090430B2 (en) * 2001-01-17 2012-01-03 Medtronic Vascular, Inc. Methods and apparatus for acute or chronic delivery or substances or apparatus to extravascular treatment sites
US6602241B2 (en) * 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US7966057B2 (en) * 2001-02-06 2011-06-21 Medtronic Vascular, Inc. Methods and apparatus for guided transluminal interventions using vessel wall penetrating catheters and other apparatus
US7892247B2 (en) * 2001-10-03 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting vessels
US7357794B2 (en) * 2002-01-17 2008-04-15 Medtronic Vascular, Inc. Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US7191015B2 (en) * 2002-04-11 2007-03-13 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US7351247B2 (en) * 2002-09-04 2008-04-01 Bioconnect Systems, Inc. Devices and methods for interconnecting body conduits
US7749239B2 (en) * 2003-04-28 2010-07-06 De Winter Erwin Screw-device for anastomosis
US20050038501A1 (en) * 2003-08-12 2005-02-17 Moore James E. Dynamic stent
US7655033B2 (en) * 2004-12-09 2010-02-02 Med Institute, Inc. S-shaped stent design
US20070106147A1 (en) * 2005-11-01 2007-05-10 Altmann Andres C Controlling direction of ultrasound imaging catheter
US20070203572A1 (en) * 2006-01-25 2007-08-30 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
US20070185567A1 (en) * 2006-01-25 2007-08-09 Heuser Richard R Catheter system with stent device for connecting adjacent blood vessels
US7374567B2 (en) * 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US20080009936A1 (en) * 2006-05-05 2008-01-10 Eidosmed, Llc Stent device for anastomoses of blood vessels and other tubular organs
US20110160751A1 (en) * 2006-06-06 2011-06-30 Luiz Gonzaga Granja Filho Extraluminal stent type prosthesis for anastomosis
US20100069820A1 (en) * 2006-09-01 2010-03-18 Zotz Rainer J Device, system, kit, and method for epicardial access
US20100087732A1 (en) * 2008-10-02 2010-04-08 Vascular Imaging Corporation Optical ultrasound receiver
US20100094391A1 (en) * 2008-10-10 2010-04-15 Kevin Heraty Stent suitable for deployment in a blood vessel
US20100113919A1 (en) * 2008-11-03 2010-05-06 Michael Maschke Catheter arangement for insertion into a blood vessel for minimally invasive intervention
US20100174357A1 (en) * 2009-01-07 2010-07-08 Lemaitre Vascular, Inc. Vascular Prosthesis of Varying Flexibility
US20110054589A1 (en) * 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same
US20110152994A1 (en) * 2009-12-22 2011-06-23 William Cook Europe Aps Implantable device
US20120065652A1 (en) * 2010-09-10 2012-03-15 Cully Edward H Anastomotic devices and methods

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398580B2 (en) 2004-09-08 2019-09-03 Limflow Gmbh Minimally invasive surgical apparatus and methods
US11446170B2 (en) 2004-09-08 2022-09-20 Limflow Gmbh Minimally invasive surgical apparatus and methods
US10136987B2 (en) 2006-04-20 2018-11-27 Limflow Gmbh Devices for fluid flow through body passages
US9108018B2 (en) 2006-04-20 2015-08-18 Limflow Gmbh Methods for fluid flow through body passages
US9326792B2 (en) 2006-04-20 2016-05-03 Limflow Gmbh Methods for fluid flow through body passages
US11241304B2 (en) 2006-04-20 2022-02-08 Limflow Gmbh Method for fluid flow through body passages
US9532803B2 (en) 2006-04-20 2017-01-03 Limflow Gmbh Devices for fluid flow through body passages
US9782201B2 (en) 2006-04-20 2017-10-10 Limflow Gmbh Methods for fluid flow through body passages
US10390933B2 (en) 2006-04-20 2019-08-27 Limflow Gmbh Devices for fluid flow through body vessels
US8632585B2 (en) * 2008-04-18 2014-01-21 Medtronic Corevalve, Inc. Apparatus for treating a heart valve, in particular a mitral valve
US20130035758A1 (en) * 2008-04-18 2013-02-07 Medtronic Corevalve Llc Apparatus for Treating a Heart Valve, In Particular a Mitral Valve
JP2018126555A (en) * 2010-11-16 2018-08-16 ティーブイエー メディカル, インコーポレイテッド Devices and methods for forming fistula
US9706998B2 (en) 2013-03-08 2017-07-18 Limflow Gmbh Methods for targeting body passages
US10524894B1 (en) 2013-03-08 2020-01-07 Limflow Gmbh Methods for effecting retroperfusion in a body passage
US10405967B1 (en) 2013-03-08 2019-09-10 Limflow Gmbh Methods for puncturing an expandable member to confirm advancement into a body passage
US10835367B2 (en) 2013-03-08 2020-11-17 Limflow Gmbh Devices for fluid flow through body passages
US11471262B2 (en) 2013-03-08 2022-10-18 Limflow Gmbh Methods for targeting a body passage to effect fluid flow
US10285800B2 (en) 2013-03-08 2019-05-14 Limflow Gmbh Systems for providing or maintaining fluid flow through body passages
US9314329B2 (en) 2013-03-08 2016-04-19 Limflow Gmbh Methods and systems for providing or maintaining fluid flow through body passages
EP3590477A1 (en) * 2013-03-08 2020-01-08 LimFlow GmbH Systems for providing or maintaining fluid flow through body passages
US9545263B2 (en) * 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10596356B2 (en) * 2014-06-19 2020-03-24 Limflow Gmbh Methods for placing a stent-graft to cover collateral vessels in lower extremity vasculature
US20190321606A1 (en) * 2014-06-19 2019-10-24 Limflow Gmbh Methods for placing a stent-graft to cover collateral vessels in lower extremity vasculature
CN111803241A (en) * 2014-06-19 2020-10-23 林弗洛公司 Apparatus and method for treating the vasculature of a lower limb
US10687833B2 (en) 2015-03-04 2020-06-23 Indiana University Research And Technology Corporation Ultrasound catheter
WO2016141281A1 (en) * 2015-03-04 2016-09-09 Indiana University Research & Technology Corporation Ultrasound catheter
US10517637B2 (en) * 2015-03-10 2019-12-31 Stent Tek Limited Surgical system for the percutaneous creation of an arteriovenous fistula (AVF)
US10881429B2 (en) 2015-03-10 2021-01-05 Stenk Tek Limited Method for the percutaneous creation of an arteriovenous fistula (AVF)
JP2018508333A (en) * 2015-03-10 2018-03-29 ステント・テック・リミテッドStent Tek Limited Surgical system, surgical device, and surgical system and method of using the surgical device for percutaneous creation of a self-vascular use subcutaneous arteriovenous fistula (AVF)
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11826504B2 (en) 2017-04-10 2023-11-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11129965B2 (en) * 2018-10-09 2021-09-28 Limflow Gmbh Devices and methods for catheter alignment
US20220008693A1 (en) * 2018-10-09 2022-01-13 Limflow Gmbh Devices and methods for catheter alignment
US11311700B2 (en) 2018-10-09 2022-04-26 Limflow Gmbh Methods for accessing pedal veins
US11478614B2 (en) 2018-10-09 2022-10-25 Limflow Gmbh Method for accessing pedal veins for deep vein arterialization
US11850379B2 (en) * 2018-10-09 2023-12-26 Limflow Gmbh Devices and methods for catheter alignment
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity

Also Published As

Publication number Publication date
WO2006027599A8 (en) 2006-05-04
GB0419954D0 (en) 2004-10-13
EP1796549A1 (en) 2007-06-20
EP1796549B1 (en) 2015-12-30
US20200054469A1 (en) 2020-02-20
US11446170B2 (en) 2022-09-20
US20140236274A1 (en) 2014-08-21
US10398580B2 (en) 2019-09-03
WO2006027599A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
US11446170B2 (en) Minimally invasive surgical apparatus and methods
US10596356B2 (en) Methods for placing a stent-graft to cover collateral vessels in lower extremity vasculature
US11826504B2 (en) Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11850379B2 (en) Devices and methods for catheter alignment
US9706998B2 (en) Methods for targeting body passages
US6508824B1 (en) Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US6709444B1 (en) Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US7179270B2 (en) Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US20230225732A1 (en) Devices and methods for increasing blood perfusion to a distal extremity

Legal Events

Date Code Title Description
AS Assignment

Owner name: ADVOTEK MEDICAL DEVICES LTD, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PACEY, ANDREW ROBERT;ROTHMAN, MARTIN TERRY;DICKINSON, ROBERT JULIAN;AND OTHERS;REEL/FRAME:020130/0272

Effective date: 20050908

AS Assignment

Owner name: SITE SPECIFIC THERAPIES LTD, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ADVOTEK MEDICAL DEVICES LTD;REEL/FRAME:020139/0731

Effective date: 20061214

AS Assignment

Owner name: LIMFLOW GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SITE SPECIFIC THERAPIES LTD.;REEL/FRAME:029462/0122

Effective date: 20120930

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: INARI MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIMFLOW S.A.;REEL/FRAME:066380/0110

Effective date: 20231031